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INTRODUCTION 
During the last 10 years, adriamycin and daunomycin have been 
major components in the treatment of cancers. However, their toxicity 
has led to the search for other anthracycline antibiotics. The less 
toxic 11-deoxyanthracyclines were discovered and have proven to be 
more effective anticancer drugs than adriamycin and daunomycin. The 
need to develop new analogues of the anthracyclines still exists; this 
manuscript will detail the results of a program to develop new analogues 
by a Diels-Alder/Friedel-Crafts acylation strategy. 
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HISTORICAL 
Since their isolation as highly colored pigments from soil bacteria, 
the anthracyclines have developed into a large family of naturally 
occurring compounds. The antitumor properties of the anthracyclines 
have stimulated this development, which has led to the isolation and 
synthesis of more clinically effective anthracyclines. Several 
excellent reviews on the anthracyclines can be found in the literature 
The name anthracycline is based on the structural features of 
this family of compounds. They all possess an anthraquinone chromophore 
within a linear tetracyclic hydrocarbon skeleton. Figure 1 illustrates 
the basic skeleton and the numbering system of the anthracyclines. They 
have been isolated as both the glycosides and the aglycones, known as 
anthracyclinones. The glycoside linkage of the anthracyclines is 
Figure 1. Skeleton and numbering system of the anthracyclines 
usually between the C-7 hydroxyl and ana-anomer of an L-sugar. 
Representatives of the anthracyclines and anthracyclinones are shown 
below. 
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Isolation and Development 
The earliest known anthracyclines were isolated by Brockmann and 
Bauer from Streptomyces purpurascens in 1950 (9a). These anthracyclines 
were found to possess the aglycones of the rhodomycins and isorhodomycins. 
These compounds were shown to have potent antibacterial activity and 
inhibited Ehrlich ascites tumors in mice, but due to their high toxicity 
there was no increase in survival rates. 
Brockmann also reported the isolation of pyrromycin from 
Streptomyces DOA 125 (9b). Similar compounds were isolated by Ettlinger 
and coworkers from Streptomyces antibioticus in 1959 (10). These 
compounds were called cinerubin A and B; they displayed activity 
against Gram (+) bacteria and certain fungi, cytotoxicity to hen 
fibroblast cultures, and inhibition of various murine sarcomas and 
carcinomas. However, their high toxicity in mice and rats prevented 
further development as antitumor agents. 
In 1963, a more selective anthracycline was independently isolated 
from a mutant strain of Streptomyces peucetius by two groups. Workers 
at Farmitalia named this compound daunomycin (11a), while workers 
at Rhone-Poulenc named it rubidomycin (lib). Daunomycin was demonstrated 
to have potent cytotoxic activity in cell cultures and to inhibit 
viruses, Ehrlich ascites tumors, and solid tumors; there was also 
substantial increase in the survival rates of treated animals (12). 
Although daunomycin is highly toxic, clinical studies were undertaken 
because of its activity against solid tumors. These studies showed it 
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had low efficacy in chronic lymphoid leukemias, lymphosarcomas, 
Hodgekin's disease, and reticulosarcomas, but it could be used for 
the treatment of acute myeloblastic and lymphoblastic leukemias (13). 
However, due to its undesirable side effects - which include severe 
aplasia, immunodepression, and severe cardiotoxicity - daunomycin had 
limited use. 
A more effective drug than daunomycin was isolated from a 
Streptomyces peucetius strain by Arcamone and coworkers in 1969 (14). 
This new drug was named adriamycin, also known as doxorubicin. Because 
adriamycin was found to be less toxic than daunomycin and active 
against a broader spectrum of tumors (15), adriamycin rapidly replaced 
daunomycin in clinical trials. Adriamycin was found to be effective 
against breast and bladder adenocarcinoma, soft tissue and osteogenic 
sarcomas, bronchogenic and testicular carcinoma, pediatric-solid 
tumors (Wilms' tumor and Ewing sarcoma), Hodgkin's disease, malignant 
lymphomas, and acute leukemias (8). Toxic side effects were alopecia, 
stomatitis, myelosuppression, gastroenteritis, and cardiac toxicity. 
Aclacinomycin A and B were isolated from Streptomyces galileus 
MA144-M1 by Oki and coworkers in 1975 (16). Aclacinomycin A was found 
to be highly active against L1210 and P388 leukemia, Ehrlich ascites 
tumors, rat hepatomas, solid tumors, and colon carcinoma. Aclacinomycin 
A showed favorable response in patients with acute leukemias (which 
were refractory to daunomycin and adriamycin), malignant lymphoma, 
and lung, breast, ovarian, stomach, and urinary bladder cancers when 
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administered by intravenous infusion (7). Aclacinomycin A was also 
moderately or weakly active against other cancers (4) and was found 
to be approximately 10 times less cardiotoxic than adriamycin in 
hamsters and rabbits (17). 
More recently, Arcamone and coworkers isolated several 11-deoxy-
anthracyclines, including 11-deoxydaunomycin and 11-deoxyadriamycin, 
from a Micromonospora peucetica strain (18). When tested in vivo 
on P388 leukemia, they were found to be just as active as adriamycin 
at 10 times the dosage. Toxicity studies have yet to be reported. 
Biosynthesis 
The biosynthesis of the anthracyclines arises from the consecutive 
"head to tail" condensation of 9 acetates and 1 propionate to produce 
the hypothetical polyketide 1 (see Figure 2). This incorporation of 
9 acetates and 1 propionate has been proven from labeling studies 
with mutated strains of Streptomyces (19). The tetracyclic ring 
system 2 is formed via aldol condensations with concomitant loss of 
water. The chrysazinanthranol derivative 3 can then be produced by 
reduction of the C-2 and C-7 carbonyls, elimination of the C-2 hydroxyl, 
and enolization. Intermediate 3 is then oxidized to aklavinone 4, 
which is the precursor for other anthracyclines (7). Daunomycinone is 
formed by a series of oxidations and a decarboxylation, while hydroxy-
lations at C-1 and/or C-11 produces e-rhodomycinone 5 and e-pyrro-
mycinone 6 (8). 
9 
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Figure 2. Biosynthesis of the anthracyclines 
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Mechanism of Action 
Researchers have also studied the mechanism of action of the 
anthracyclines. Their antitumor activity is due to binding inter­
actions between the drug and deoxyribonucleic acid (DNA). When double-
stranded DNA and anthracyclines are mixed in solution, there are 
noticeable changes in the physical and spectral properties of these 
compounds (20). The anthracycline's ultraviolet, visible, fluorescence, 
and polarographic properties are changed, while the sedimentation 
rate, viscosity, and denaturation profile of the DNA are also changed. 
This information and data from X-ray diffraction studies of anthra-
cycline-DNA complexes (21) indicate that the anthracycline intercalates 
between the base pairs of the DNA helix. 
The X-ray analysis of N-bromoacetyldaunomycin, along with NMR 
analyses, have shown that the A ring exists in a half chair conformation 
(22). This conformation is stabilized by the intramolecular hydrogen 
bonding between the C-7 oxygen and the C-9 hydroxyl hydrogen (Figure 3). 
Figure 3. Conformation of the A ring 
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With this information and the previous data, a detailed model for the 
binding interaction can be proposed. The major binding force is the 
extensive overlap between the planar anthraquinone chromophore of the 
anthracycline and the two adjacent base pairs of the DNA, which 
are immediately above and below the planar chromophore. Stabilization 
of this interaction is due to a variety of ionic and hydrogen bonding 
interactions between the electron-deficient quinone chromophore and 
the electron-rich purine and pyrimidine bases (8). Also, additional 
stabilization can occur by the ionic interactions of the anthracycline's 
amino sugar moiety (which is in the major groove of the DNA helix) 
and the phosphates of the DNA. These interactions occur between the 
protonated amino group of the sugar and the second phosphate from the 
intercalation site. Hydrogen bonding between the C-9 hydroxyl and the 
first phosphate from the intercalation site is also possible. 
The direct consequence of this intercalation is the inhibition 
on the template activity of the DNA, thus causing the death of the 
cancer cell. However, the detailed mechanism of this inhibition 
remains to be established; both preventing the separation of the DNA 
strands and hindering the attachment of the polymerase (due to the 
distortion of the DNA structure) have been suggested as possible 
causes for this inhibition of DNA synthesis (23). 
However, this intercalation of DNA cannot account for the breakage 
of DNA strands, breakage which has been observed in vivo and in vitro. 
Kleyer and Koch have recently reported that the reduction of 
12 
daunomycinone to hydroquinone 8 occurs via two sequential one-electron 
reductions (24). Previous evidence indicates that the enzyme NADPH, 
which is present in the microsomes of cells, catalyzes this reduction 
0 HO OH 0 HO HO ÔÔÔ OH OH OH 
OH 
of the quinone chromophore to produce the semiquinone 7 (25). Sato 
and coworkers have shown that semiquinone 7 forms in vitro and that 
no radicals are formed by the drug-DNA complex with NADPH (26). Thus, 
semiquinone 7 must be formed before intercalation of the DNA occurs. 
In the presence of molecular oxygen, semiquinone 7 acts as an electron 
shuttle by producing superoxide radicals; by intercalating into the 
DNA helix, superoxide can be generated in proximity of the DNA strands 
causing the damage to the strands (25). 
Lown and coworkers have reported that no cleavage of DNA occurred 
with the addition of anthracyclines, but when an anthracycline/DNA 
mixture was treated with a reducing agent (NaBH^ ), cleavage was 
observed at a slow rate (27). Rapid cleavage was observed when 
hydroquinone 9 was added to a DNA solution, thus indicating that the 
intercalated quinone chromophore is shielded from the reducing agent. 
They also reported that less cleavage occurred with the reduced aglycones, 
revealing the importance of.the amino sugar-DNA interactions. Oxidation 
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of hydroquinone 9 by molecular oxygen could generate superoxide and 
peroxide (Figure 4), which can then damage the DNA strands. This 
HO HO HO Hp 
 ^+02 
H3CO HO HO OR w CO 0» 0 OR 
9 10 
HOg" > h"" + Og-
ZOL' + 2H'^  > HgOg + 0-
HgOg + Og" > HO- + HO" + Og 
HO" + DNA > damaged DNA 
Figure 4. Generation of superoxide and peroxide 
mechanism also accounts for the cardiotoxicity of the anthracyclines. 
Since heart tissue has low levels of catalase and superoxide dismutase, 
Nohl and Jordan have suggested that the cardiotoxicity is due to the 
generation of the hydroxide radical and not superoxide (28). 
In the absence of molecular oxygen, reduction of anthracyclines 
results in the formation of the 7-deoxyanthracyclines (29) and covalent 
binding of the drug to cellular macromolecules (30) via a semiquinone 
intermediate. This covalent binding has also been suggested to occur 
from the hydroquinone intermediate via a quinone methide (31). The 
existence of quinone methide 11 has been demonstrated from kinetic and 
14 
spectroscopic studies (32). Furthermore, quinone methide U has been 
trapped by benzaldehyde (33) and by thiol and thiolate nucleophiles 
(34). Thus, quinone methide 11 can react with either electrophilic 
HO HO 
+ HOR 
H3CO HO HO OR 
or nucleophilic sites of the DMA. Kinetic and spectroscopic studies 
on aclacinomycin A suggest that reductive elimination of the glycoside 
forms quinone methide 12, which can be protonated or dimerize to dimer 
01 lOI > 
HO 0 HO 
^ Hp HO HO 
HO 0 HO 
CO2CH3 
13 (35). The absence of the 11-hydroxy in quinone methide 12 makes it 
less basic and nucleophilic and more electrophilic than quinone methide 
11. These differences result in the formation of dimer 13 and may be 
responsible for their differences in biological activity. By binding 
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to the DMA, the anthracycline can prevent DNA synthesis and generate 
reactive oxygen species in the proximity of the DNA strands. 
Structure-Activity Relationships 
The outstanding cancer chemotherapeutic efficacy of adriamycin has 
stimulated the search for anthracyclines that do not exhibit the severe 
and cumulative dose-dependent cardiotoxicity of adriamycin. This 
search has led to the clinically effective aclacinomycin A by Oki and 
coworkers. By the use of microbial and chemical glycosidation, 
modification, and isolation, the relationships between structure and 
activity of over 61 anthracyclines have been studied (7). A brief 
summary of these relationships is outlined below: 
1. The amino group of the sugar moiety is essential for activity. 
2. Anthracyclines with di- or trisaccharides are more potent in vitro 
than the monosaccharide compounds. 
3. Hydroxyls at C-1, C-2, C-4, C-6, and C-11 influence the in vitro 
and vivo activity. 
a) Compounds without the C-6 hydroxyl group have lower cytotoxicity 
and inhibitory effect on RNA and DNA synthesis than those with 
the C-6 hydroxyl. 
b) Replacement of C-4 or C-6 hydroxyl with a methoxyl decreases 
the potency of the drug. 
c) Hydrophobicity at C-4 and ^  vitro potency increase in parallel: 
CHjO < HO < H. 
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d) Hydroxyls at C-1 and/or C-11 increase the potency but decrease 
the antitumor activity due to their toxicity. 
4. The C-10 methoxycarbonyl with R-configuration is important in the 
inhibition of RNA synthesis. 
5. The length of C-9 side chain has a slight influence on cytotoxicity 
and inhibition of RNA and DNA synthesis. 
DiMarco and coworkers have reported that methylation of the C-6 
and C-11 hydroxyls of daunomycin results in complete loss of bioactivity 
and affinity for DNA (36). Methylation of the C-6 or C-11 hydroxyl 
of A-O-demethyldaunomycin did not destroy its bioactivity, thus 
indicating the importance of a chelated quinone chromophore. 
The length of the saccharide is important in inhibiting DNA and 
RNA synthesis (37). Anthracyclines with a monosaccharide chain inhibit 
DNA and RNA synthesis at approximately equivalent concentrations. 
However, anthracyclines with a polysaccharide chain Inhibit RNA synthesis 
at lower concentrations than those needed for DNA inhibition. The 
inhibition of RNA synthesis at lower concentrations is due to the 
polysaccharide occupying the major or minor groove of the DNA helix, 
thus interfering with the movement of RNA polymerase (38). The poly­
saccharide can also decrease the DNA inhibition by decreasing the 
binding of the drug to the DNA. 
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Synthetic Approaches 
Both A-demethoxydaunomycin ^  and 4-demethoxyadriamycin 15 have 
been synthesized, and their properties have been studied (8). While 
0 HO 
HO "^2 
j4 R=H 
is R=OH 
4-demethoxydaunomycin was found to be 8 times more active than 
daunomycin, it was also more toxic than daunomycin. The 4-demethoxy- ' 
adriamycin was found to be more effective at lower doses than adriamycin 
and was also found to be orally active. 
Because of these findings and the previously given structure-
activity relationships, synthetic chemists have begun to synthesize 
the deoxyanthracyclines in hopes of developing new anthracyclines with 
diminished toxicity, improved activity, and facile preparation. 
Any synthetic approach to the deoxyanthracyclines must overcome 
two synthetic problems. These problems are regioselective formation 
of the linear tetracyclic skeleton and introduction of the C-7 hydroxyl. 
The latter problem is usually accomplished via a benzylic bromination/ 
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solvolysis sequence. However, the efficiency of this sequence varies 
from excellent for the ll-deoxyanthracyclines to poor for the 6-deoxy-
anthracyclines and daunomycin series. The formation of the tetracyclic 
skeleton of the deoxyanthracyclines can be divided into several 
strategies: Friedel-Crafts acylation and alkylation, cycloadditions, 
and anionic approaches. A brief summary of previous synthetic efforts 
towards the deoxyanthracyclines involving these strategies will be 
given. 
The Friedel-Crafts reaction has played an important role in the 
synthesis of the deoxyanthracyclines. Wong and coworkers have used 
an AB + D strategy in their synthesis of 4-demethoxydaunomycinone (39). 
Their synthesis involved the acylation of tetralin 17 with the phthalic 
acid monomethyl ester alkaline hydrolysis, and subsequent cyclization 
to afford anthraquinone 18 in a 23% yield. This intermediate was then 
transformed into 4-demethoxydaunomycinone in several steps. Several 
similar syntheses of 4-demethoxydaunomycinone have been reported (40). 
Johnson and coworkers have utilized a convergent Freidel-Crafts 
alkylation strategy in their synthesis of ll-deoxydaunomycinone (41). 
Alkylation of tetralin 20 with bromophthalide 19 produced phthalide 21 
18 
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(with complete control of regiochemistry) in 86% yield. Transformation 
of phthalide 21 to anthraquinone 22 was accomplished in excellent 
yields via hydrogenolysis, cyclization, and oxidation. Anthraquinone 
22 was then successfully converted to 11-deoxydaunomycinone. Rama Rao 
and coworkers have reported a similar synthesis (42). 
Confalone and Pizzolato have synthesized aklavinone by the use of 
the Fries rearrangement (43). Aryl ester 23, which was prepared from 
the corresponding tetrahydronaphthol and methoxy phthalic acid monomethyl 
ester, gave exclusively the o-hydroxybenzophenone ^  in 73% yield at 
1200C. At lower temperatures, a mixture of ortho/para isomers was 
obtained. Saponification and cyclization produced anthraquinone ^  in 
57% yield which was subsequently transformed into alkavinone; however, 
the overall yield for this synthesis is extremely poor. A similar 
strategy has been used for the formation of a 11-deoxydaunomycinone 
intermediate (44). 
20 
OCT DTT3 Pv H:tCO 0 OH 
25. 
Aklavinone has also been synthesized by Kende and Rizzi via an 
AB + D strategy (45). Addition of aldehyde ^  to the metallated 
carboxamide ^  followed by cold acidic workup gave phthalide 28 in 
80% yield. Phthalide ^  was converted into anthraquinone 29 via 
hydrogenolysis, cyclization, and oxidation in an overall yield of 56%. 
Functionalization of the A ring resulted in a stereospecific and 
enantioselective synthesis of aklavinone in an overall yield of 6.5%. 
Decarbomethoxyaklavinone (46) and 11-deoxycarminomycinone (47) have 
also been synthesized by this strategy. 
OR OU OR OR 
OCH 
26 " 27 R=Si 
Vedejs and Nader have used an A + CD strategy in their synthesis 
of a 4-demethoxy-ll-deoxyanthracycline intermediate, which possess 
the necessary oxygenation at C-7 (48). A 1,4-addition of benzyl anion 
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30 to cyclohexenone and subsequent trapping of the resulting enolate 
gave thioester 31 in 66% yield. Cyclization of thioester 31 with cuprous 
triflate and oxidation with silver (II) oxide produced anthraquinone 
32 in 56% yield. Thioester 31 is an ideal enolate carboxylation 
product because it can be cyclized without activation. 
H3C 9 R H^CO R 
H3CO H3C6 40 0 HO 0 
^ R-Si(CH3)3  ^
Another A + CD approach to the 11-deoxyanthracyclines involved 
the addition of lactone 34 to the metallated naphthalene 33 to produce 
ketoester ^  in 73% yield (49). Ketoester ^  was converted to tetra­
cyclic diketone 36 in 8 steps (27% yield). Anthraquinone 37 was 
obtained in 29% yield from tetracyclic diketone 36 in 6 steps. 
"3CO3 31 
H3C0^ 0 0 
"3CO 35 
H3CO 
"'QH E=C02CH3 
H3CO 0 0 H3CO 0 OH 
CH3 
36 37 
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Penco and coworkers have used a similar approach in their synthesis 
of A-demethoxy-6-deoxydaunomycinone (50). Their route was extremely 
short (10 steps), but the formation of anthraquinone 40 from naphthalene 
38 and aldoester 39 was extremely poor (10% yield). 
H3CO 0 HO 
I J > 
H3C0 0 b 
38, 4Q 
Tetracyclic diketone % has also been prepared by Rama Rao and 
coworkers (51). Cycloaddition of 2-methoxy-l,3-butadiene with a,g-
unsaturated ester ^  (produced in a 20% yield from naphthoquinone 41) 
followed by acidic hydrolysis gave ketoester ^  in 60% yield. 
Saponification and cyclization produced- tetracyclic diketone 36 in 
excellent yield. A similar strategy was used in the synthesis of 
4-demethoxydaunomycinone (52). 
0 H3CO H3CO 
H3CO 0 H3CO OCHj H3CO OCH3 E^COzCgHg 
& & 
The application of the Diels-Alder reaction to build up the 
tetracyclic ring system of the deoxyanthracyclines has been widely 
explored and represents one of the most attractive and versatile 
approaches. As in the case of the Friedel-Crafts approaches, the 
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tetracyclic skeleton of the deoxyanthracyclines can be formed via the 
AB + D strategy. Kende and coworkers have used this strategy in their 
synthesis of 4-demethoxydaunomycinone (53). Cycloaddition of isobenzo-
furan 44 (generated Ln situ) with tetrahydronaphthoquinone 45 and 
subsequent aromatization produced tetracyclic quinone 46 in 67% yield. 
Anthraquinone 47 was synthesized in 40% yield from quinone 46 via 
reductive acetylation of the quinone, oxidation of the C ring, and 
hydrolysis of the acetates. A benzylic bromination/solvolysis sequence 
produced the desired product in a moderate yield. 
0 HO 0 
OH 
0 HO 
47, 
Anthraquinone 47 has also been constructed by Wiseman and coworkers 
(54). Their route is very similar to the previous one and involves the 
trapping of o-quinodimethide 48, which is generated Dn situ from the 
tetrabromide, with tetrahydronaphthoquinone However, tetracyclic 
quinone 50 was produced in only 33% yield. 
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Another route to 4-demethoxydaunomycinone via o-quinodimethides 
has also been reported (55). Trapping of the o-quinodimethide generated 
from the thermal ring opening of benzocyclobutene 51 with tetrahydro-
naphthoquinone 52 produced tetracyclic quinone 53 in 79% yield. This 
synthesis of 4-demethoxydaunomycinone solves the problems associated 
with the introduction of the C-7 hydroxyl and is accomplished in a 
good overall yield. These are the only examples of the AB + D strategy. 
However, the A + CD strategy has received more attention from 
synthetic chemists. Tamura and coworkers have prepared the 11-deoxy-
carminomycinone intermediate 56 by the cycloaddition of diene 55 and 
O-methyl-3-bromojuglone 54 with excellent control of the regiochemistry 
and in 78% yield (56). A similar route has been reported by Jung and 
coworkers (57). 
0 
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The cycloaddition of vinyl ketene acetals (A ring synthons) with 
naphthoquinones has been shown to produce tetracyclic intermediates 
with control of regiochemistry and in moderate yields (58). Gesson and 
Mondon have extended this work in their synthesis of 11-deoxydaunomycinone 
(59). Cycloaddition of vinyl ketene acetal 57 with O-methyl-3-bromo-
juglone 54 and subsequent deketalization produced anthraquinone 58 
in 71% yield. However, conversion of anthraquinone 58 to 11-deoxy­
daunomycinone was accomplished in a poor overall yield. Gesson and 
coworkers have also constructed 6-deoxyanthracycline intermediates 
in moderate yields via vinyl ketene acetal 59 (60). 
TMS=SKCH3)3 
Vinyl ketene acetals generated by the thermolysis of cyclobutenes 
have also been used for the construction of the deoxyanthracycline 
skeleton. Both 6-deoxydaunomycinone and 6-deoxyadriamycinone have been 
synthesized from anthraquinone 62 (61). However, anthraquinone ^  was 
OTMS 
TMS=S«{CH^ 3 57 & 
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prepared in a 4:1 mixture of regioisomers (93% yield) from vinyl ketene 
acetal 61, which was generated in situ from the corresponding cyclo-
butene, and 0-methyljuglone 60. 
Boeckman and Sum have also used this approach in their synthesis 
of aklavinone (62). Cycloaddition of the thermally generated vinyl 
ketene acetal 64 with juglone 63 produced the anthraquinone 65. As 
in the previous example, a mixture of regioisomers was formed. 
An additional approach using the cycloaddition strategy utilizes 
a BCD ring intermediate. Kimura and coworkers have recently reported 
an extremely short and efficient synthesis of a 4-demethoxydaunomycinone 
intermediate based on this approach (63). The cycloaddition of 
2-chloro-l,3-butadiene with quinizarin quinone 66 (prepared in 58% 
yield from quinizarin) produced the tetraketone 67 in excellent yield. 
This cycloaddition takes advantage of the subtle differences in 
H3< 
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reactivity of the internal double bond versus the external double bond 
of quinone 66 with electron poor dienes (64). The conversion of 
tetraketone 67 to anthraquinone 68 was accomplished in 89% yield via 
aromatization of the B ring and hydrolysis of the vinyl chloride. 
® ® 0 0 0 HO 
66  ^ 68 
Similar syntheses of 4-demethoxydaunomycinone have been reported. 
Kelly and Tsang have prepared the tetraketone 70 in excellent yield 
from quinone 66 and diene 69 (65). Tetraketone 70 was converted to 
66 
0 0 
0 0 
0 H 
anthraquinone 47 in 5 steps (40% yield). Garland and coworkers have 
prepared tetraketone 72 from diene 71 in a 11% yield (66). This 
synthesis has a distinct advantage over the previous two in that the C-7 
hydroxyl is introduced in excellent yield via the benzylic trimethyl-
silyl group. 
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0 HO OH 
Several approaches to solve the problem of internal addition of 
electron rich dienes to quinone 66 have been reported. Epoxidation 
of quinone 66 produces oxirane 73, which forces cycloaddition to occur 
at the external double bond (67). Using this strategy, Jackson and 
Stoodley prepared tetraketone 75 in 70% yield from oxirane 73 and diene 
74 (68). Tetraketone 75 was smoothly converted to the 4-demethoxy-
0 HO 
)TMS 07ms 
OCH OCH3 
daunomycinone derivative 76. Alternatively, quinizarin can be reduced 
to the tricyclic quinone 77 in excellent yield (69). Cycloaddition of 
quinone 77 with 1,3-butadiene, followed by aromatization and acetylation, 
produced anthracene 78 in 68% yield. Bromination, oxidation, and 
debromination of anthracene 78 gave anthraquinone 79, which was easily 
transformed into anthraquinone 68. 
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79. 
The use of o-quinodimethides as BCD ring intermediates has also 
been reported. Cava and coworkers have trapped o-quinodimethide 81 
(generated from anthraquinone 80) with methyl vinyl ketone to produce 
anthraquinone 82 in moderate yields (70). The anthraquinone 80 can 
be readily prepared from quinizarin. Anthraquinone 82 was then 
0 OR 8r 
Diia 
OR Br 
R=CH3 
•CI3 
elaborated to anthraquinone 47 in 3 steps and has also been used in an 
asymmetric synthesis of 4-demethoxydaunomycinone (71). Also, o-quino-
dimethide ^  has been trapped with dienophile 83 in 12% yield and 
dienophile 84 in 46% yield to give the C-9 oxygenated anthraquinone 85 
(72). 
tHjC )3SiO 
83 
V 
84, 
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The generation of o-quinodimethides from the thermal ring opening 
of benzocyclobutenes 86 and 87 has also been reported (73). This route 
is an improvement on the previous route because it occurs in higher 
yields, uses a smaller ratio of diene to dienophile, and has wider 
applications. 
Naphthazarin 90 has been used as an effective starting material 
for the construction of tetracyclic skeletons (74). Krohn and Rosner 
have synthesized 4-deoxy-ï-rhodomycinone from naphthazarin in an 
excellent overall yield (74a). Their synthesis involved the formation 
of tricyclic quinone 91, which can undergo a second cycloaddition (via 
its tautomer) to produce the tetracyclic quinone 92. A similar approach 
was used to synthesize 4-demethoxydaunomycinone (74b). 
0 OR \ 0 OR ^ 
§6^  R=H  ^R=H 
§1 R-CH3  ^R=CH3 
89 R=H 
82 R=CH3 
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Several other examples of constructing the carbon skeleton of the 
deoxyanthracyclines via the cycloaddition strategy have been reported 
The last strategy to be summarized is the anionic approach. 
Mauser and coworkers have developed a phthalide sulfone annelation 
strategy, which is convergent, efficient, and regiospecific (76). 
Recently, Mauser and Mai have reported the synthesis of aklavinone and 
E-pyrromycinone from phthalide sulfones 93a and 93b, respectfully (77). 
Condensation of enone 94 with the phthalide sulfones 93 produced the 
anthraquinones 95 in excellent yield. Formation of the A ring was 
accomplished via an intramolecular aldol cyclization. In both cases, 
the major product was the desired isomers 96 and 97. This strategy 
was also used for the synthesis of y-citromycinone (78). Condensation 
(75). 
O^ Ph 
93^  R-OCH3 
H3UU u HO 
 ^ E=Cp2CH3 
H3CO 0 HO 
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of enone 99 with phthalide sulfone 98 produced anthraquinone 100; 
however, the yield was only 55%. The A ring was formed by a Claisen 
rearrangement and subsequent cyclization of anthraquinone 101 with 
tin tetrachloride. 
0 HO 
H3CO S02Ph OAc H3CO 0 OAc 
98 ^ 100 
0 HO 
H3CO 0 
Aklavinone has also been prepared by the use of a cyanophthalide 
(79). The anthraquinone 104 was formed from the addition of cyano­
phthalide 102 to enone ^ 3 and subsequent air oxidation and esteri-
fication; the overall yield for this transformation was 42%. 
° H,CO 0 HO 
m 104. 
Diia 
Intramolecular cyclization of an anthraquinone intermediate has 
been an important strategy in the synthesis of deoxyanthracycline 
intermediates (80). One of the first syntheses of aklavinone was 
accomplished by this approach (81). Anthraquinone 106 was prepared 
from benzofuran in 70% yield via ozonolysis and aldol condensation. 
Intramolecular cyclization of anthraquinone 106 produced a mixture of 
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aldol products 107. However, this mixture could be equilibrated. 
Thus, the overall yield of aklavinone from 2-bromojuglone (precursor 
to benzofuran ^ 5) was 37% with the equilibrations. This work has 
been extended to include the asymmetric syntheses of aklavinone (82) 
and 11-deoxydaunomycinone (83). 
A similar approach was used by Maruyama and coworkers in their 
synthesis of aklavinone (84); however, both the A and B rings were 
formed via the intramolecular cyclization of naphthalene ^ 8. As in 
the previous case, a mixture of products was obtained with the desired 
tetracyclic ketone 109 isolated in a 53% yield. 
Vedejs and coworkers have reported a silicon mediated approach 
to the 11-deoxyanthracyclines (85). Cycloaddition of ketoacetylene HO 
and diene 111 gave adduct 112 in 86% yield and the isomeric adduct in 
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8% yield. Adduct U2 was then transformed into the benzyl cyanide 113 
in 5 steps. Hassall cyclization, oxidation, and deketalization produced 
anthraquinone 114 in a good overall yield. 
0 n ^ Q 
OR 
OR 
110 
R3S' 
0 
I I I  
RsSi V® 
CN OR 
Dxxa 
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R=CH3 114, 
The last anionic approach is the 1,4-addition of metallated 
quinone bisketals to benzocyclobutenones. Using this approach, Swenton 
and coworkers have prepared 4-demethoxydaunomycinone from anthraquinone 
117, which was prepared by the addition of benzocyclobutenone 115 to 
the lithiated quinone bisketal 116 in 62% yield (86). This strategy 
RO OR 
RO 0 OR 
0 OR 
r=ch3 jjx 
has also been used to synthesize a-citromycinone via the addition of 
benzocyclobutenone 118 to the lithiated p-quinol synthon 119 (87). 
35 
Although this strategy allows the use of a functionalized A ring 
intermediate and occurs regioselectively, the overall yields are 
relatively low. 
In conclusion, the anthracyclines are an important class of anti­
tumor antibiotics which have proven successful in clinical trials. 
However, their cardiotoxicity has been a major drawback of these drugs. 
Thus, chemists have developed analogues which are both more therapeutic 
and less toxic. The synthetic approaches to these analogues are varied 
and include the Friedel-Crafts acylation and alkylation, cycloadditions, 
and anionic approaches; overall, these strategies have been used 
effectively to produce these analogues, but improvements to these 
strategies are needed. 
'O-^ OR 
118 R=CH3 
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RESULTS AND DISCUSSION 
Since their isolation, the anthracyclines have developed into an 
important class of antitumor agents. Their high biological activity, 
especially for the deoxyanthracyclines, has prompted considerable 
synthetic attention. Both the Diels-Alder reaction and the Friedel-
Crafts reaction have played important roles in the synthesis of this 
class of compounds; however, relatively few syntheses have used a 
combination of these two powerful reactions. Since certain Lewis 
acids (AlClj, BF^ -OEtg, SnCl^ , and ZnCl^ ) are known to catalyze both 
the Diels-Alder and the Friedel-Crafts reaction, we anticipated that 
the tetracyclic skeleton of the anthracyclines could be rapidly 
constructed from the tandem Diels-Alder/Friedel-Crafts strategy 
shown below. Such a strategy is not only convergent and regiospecific, 
but it would also introduce the C-7 hydroxyl group via the carbon-
carbon double bond. 
To test the viability of this strategy, diene ]^ 1 was chosen as 
a model system. Diene 121 was easily prepared by the lithiation of 
p-dimethoxybenzene and subsequent addition of 2,4-hexadienal to produce 
benzyl alcohol ^ 0, which was unstable to chromatography. Methylation 
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of the crude alcohol afforded diene 121 in an excellent overall yield. 
Only decomposition of diene 121 was observed when the acid catalyzed 
reaction was attempted under a variety of conditions (AlCl^ , 0°C, 
OR OR RO 
OR RO OH RO OR 
R=CH3 j20 121 
-78°C; SnCl^ , -78°C; BF^ -0Et2, -78°C). As a result of this failure, 
we decided to examine a sequential Diels-Alder/Friedel-Crafts strategy. 
Cycloaddition of diene 121 with maleic anhydride gave adduct 122 
in 77% yield. Adduct 122 was determined to be a single diastereomer 
by ^^ C-NMR. While the cycloaddition is assumed to give the endo-
product, the stereochemistry of the benzylic methoxyl group was not 
determined. 
121 + 
RO OR 
RO 0 
R=CH, 123 
Treatment of adduct 122 with several Lewis acids (AlCl^ , SnCl^ , 
and BF^ 'OEt-) resulted in the formation of lactone 123 in 79% yield. 
Due to the good overall yield of lactone 123, we attempted to use this 
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unexpected product to our advantage. Numerous examples of hydro-
genolysis of phthalides to the corresponding acids have been reported 
(88). However, all attempts to hydrogenolyze lactone 123 failed. 
With the formation of lactone 123, it appeared necessary to remove 
the benzylic methoxyl group. Since dissolving metal reductions are 
known to deoxygenate benzyl alcohols (89), we anticipated the 
deoxygenation of adduct 122 via the biscarboxylate salt (which 
122 
RO OR 
Li/NHg 
RO 
R=CH3 J25, 
prevents the ammonolysis of the anhydride) would provide diacid 125. 
Hydrolysis of adduct 122 with potassium hydroxide and subsequent 
reduction with lithium/ammonia afforded diacid 125 in 89% yield. 
Diacid 125 was used without further purification. 
While attempted cyclization with aluminum chloride resulted in 
the formation of an emulsion and the loss of the diacid, attempted 
cyclization with trifluoroacetic anhydride (TFAA) resulted in the 
formation of anhydride 126 in 70% yield. Cyclization was finally 
accomplished by treating anhydride 126 with aluminum chloride. 
Ketoester 127 was produced in 82% yield after esterification with 
diazomethane. The success of this cyclization demonstrated that the 
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Diels-Alder/Friedel-Crafts strategy can be a useful approach; however, 
the need to remove the benzylic methoxyl group makes this route very 
awkward. Unfortunately, all attempts to produce the deoxygenated diene 
failed. 
cOgR 
,25 ^  
I) AiCI 
2) CH2N2 
R=CH 
Because of the necessity of having a deoxygenated benzylic 
position and the success of the lithium/ammonia reduction, we believed 
that a furan ring would be an excellent choice for the diene moiety. 
Furans are known to readily undergo cycloaddition with maleic anhydride, 
are stable to the reduction conditions, and would allow us to easily 
incorporate the C-9 hydroxyl group. The required benzylfuran 128 was 
prepared by a tandem alkylation-reduction sequence (90) in 68% yield 
from p-dimethoxybenzene. 
RO 
I) n-BuLi 
H " RO OLi 
Li/NHg 
R=CH3 
RO 
OR 
128. 
AO 
Since the failure of the tandem Diels-Alder/Friedel-Crafts 
strategy was due to the benzylic methoxyl group, we decided to reconsider 
this strategy with benzylfuran 1^ . As in the previous approach, all 
attempts to cyclize resulted in the decomposition of the benzylfuran. 
As a result, we focused our attention on the sequential Diels-Alder/-
Friedel-Crafts strategy. 
Cycloaddition of benzylfuran 128 with maleic anhydride was readily 
accomplished in the absence of light. In the presence of light, an 
unidentifiable mixture was formed. Boberg and Schultze have also 
reported a light sensitive cycloaddition of substituted furans with 
maleic anhydride (91). Adduct 1^  was obtained in excellent yield by 
simple filtration. Since adduct 129 was found to undergo retro-cyclo-
addition in solution, crude adduct was catalytically hydrogenated to 
provide anhydride 130 in 83% yield after recrystallization. Having 
synthesized anhydride ^ 0 and having cyclized anhydride 126, we 
anticipated the cyclization of anhydride ^ 0 would produce ketoester 
131 under similar conditions. 
RO 
128 129 
OR OR 
130 R=CH3 131 
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However, this cyclization proved more difficult than anticipated. 
While reaction of anhydride 130 with aluminum chloride can demethylate 
starting material, reaction at ambient temperature provided the desired 
ketoester 131 in low yield. Because aluminum chloride can demethylate 
aryl methyl ethers, the low yield was probably due to this side 
reaction. Thus, other Lewis acids which do not demethylate aryl 
methyl ethers were tried. These results are summarized in Table 1. 
Table 1. Attempted cyclizations of anhydride ^ 0 
Lewis Acid Solvent Temperature Result^  
AlClj CHgClg G°C S.M. 
AICI3 CHgClg 25*0 131 (35%) 
AlCl^  chgciych nog 0°C dec. 
AlClj chgclg/ch^nog -2ooc S.M. 
SnCl^  chgclg 25°C S.M. 
sncl* CICH2CH2CI 85=0 S.M, 
TiCl^  CHgClg 25°C S.M. 
H^ PO^  clchgchgcl 85°C S.M. 
hcio4 CHgClg 25°C S.M. 
®S.M. = starting material; dec. = decomposition. 
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Due to the reluctance of anhydride OO to cyclize, it appeared to 
us that the rigid [2.2.1] oxabicycloheptane system of anhydride 
was preventing cyclization. Thus, we decided to modify this rigid 
ring system in the hope that cyclization could then be accomplished. 
Yuldashev and Tsukervanik have reported the formation of acid 
133 from methanolysis of anhydride 1% (92). The selectivity of the 
methanol addition is due to the attack at the least hindered carbonyl 
of the anhydride. This selectivity was also observed for similar 
systems. 
Methanolysis of anhydride ^ 0 provided acid 134 in quantitative 
yield. The regiochemistry of acid 134 was assumed to be as shown due 
to the attack at the least hindered carbonyl. This regiochemistry 
was proven to be correct by the cyclization of acid 134 to trifluoro-
acetate ^ 5 with trifluoroacetic anhydride. The unexpected aromatization 
is attributed to the formation of trifluoroacetic acid (TFA) during the 
cyclization. The trifluoroacetic acid can enolize the ketone inter­
mediate and can protonate the bridgehead oxygen. Cleavage of the 
bridgehead carbon-oxygen bond and acetylation of the hydroxyl group 
H2 
Pd/Al203 
COgCHj 
CO2H 
132 133 
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would produce trifluoroacetate 135. Because trifluoroacetate 135 was 
not stable to chromatography, the crude product was hydrolyzed to 
hydroxyester 136 with potassium cyanide in methanol (93). The overall 
yield of hydroxyester 136 from acid 134 was 74%. Earlier attempts to 
hydrolyze the acetate with potassium carbonate in methanol (94) gave 
hydroxyester 136 in 50% yield. In the 300 MHz proton NMR of trifluoro­
acetate 135, the benzylic methine proton at 4.60 6 was a doublet with 
a coupling constant of 7 Hz, which is in good agreement with a trans-
relationship between the trifluoroacetate and the carbomethoxy group. 
This stereochemistry indicates that the cycloaddition gave the endo-
adduct, an assumption which is also supported by the chemical shifts 
of acid 134 (95). 
After the successful cyclization of acid 134 without Lewis acids, 
we decided to determine if the benzylic methoxyl group could be present 
during cyclization. Thus, benzylfuran 138 was prepared in good overall 
yield by the methylation of benzyl alcohol 137 with sodium hydride and 
methyl iodide. Cycloaddition of benzylfuran 138 with maleic anhydride 
furnished the desired adduct; however, this product was extremely 
unstable and would decompose as a solid. Due to this instability. 
dtfaa 
130 R=CH3 J34 135 RpOCCFg 
136 RpOH 
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the crude adduct was immediately hydrogenated to afford anhydride 139, 
as a mixture of diastereomers, in 58% yield. Although adduct 122 was 
ro 
ro 
I) n-BuLi 
ro 
ro oh 
137 
1) NoH 
2) rl 
ro or 
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i) ron 
ro q co2r 
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ro 
r = ch3 140 
produced as a single diastereomer, benzylfuran 1^  gave a mixture of 
endo- and exo-adducts due to the retro-cycloaddition reaction (96). 
Methanolysis of anhydride ^ 9 furnished the required acid in 
quantitative yield. However, attempted cyclizations of this acid with 
trifluoroacetic anhydride resulted in the formation of lactone ^ 0. 
Thus, it is apparent that the benzylic methoxyl group cannot be 
present during cyclization. 
As a result of this failure, we directed our attention to the 
formation of a tetracyclic intermediate via the naphthylfuran 1^ . 
Initial attempts to prepare naphthylfuran 143 by the tandem alkylation-
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reduction sequence resulted in the formation of dihydronaphthalene 1^  
from 2-bromo-l,4-dimethoxynaphthalene ^ 1 (97). Dihydronaphthalene 
142 could be converted into the desired naphthylfuran with 2,3-di-
chloro-5,6-dicyanobenzoquinone (DDQ); however, the overall yield was 
extremely poor. Due to the competitive reduction of the naphthalene 
ring, other dissolving metal reductions (Ca/NH^ /EtOH (98); Zn/CuSO^ / 
NH^  (99)) and ionic hydrogénations (Et^ SiH/TFA (100); NaBH^ /TFA (101)) 
were tried, but all failed to give the desired product. Ionic 
hydrogénation with triethylsilane and boron trifluoride etherate (102) 
produced naphthylfuran 143, but in only 20% yield. 
We anticipated that the introduction of an electron-donating 
methoxyl group to the unsubstituted naphthalene ring would prevent 
the competitive reduction of this ring. The required naphthalene, 
3-bromo-l,4,5-trimethoxynaphthalene ]^ , was prepared in excellent 
yield by the methylation of 2-bromo-4,8-dimethoxynaphthol 1# (103). 
Unfortunately, the tandem alkylation-reduction with the trimethoxy-
naphthalene M5 resulted in the formation of a complex mixture. 
I) n-BuLi 
RO 
142 R=CH3 
RO 
143 141 
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R = CH3 145 
Naphthylfuran was finally obtained in good overall yield via 
a cuprate coupling. Chloromethylation (104) of 1,4-dimethoxynaphthalene 
6^ (97) produced 2-chloromethyl-l,4-dimethoxynaphthalene 147. Coupling 
naphthalene 147 with di(2-furyl)copper lithium afforded napthylfuran 
143 in an overall yield of 50% from inexpensive and readily available 
starting materials. 
Cycloaddition of napthylfuran 143 with maleic anhydride at ambient 
temperature and subsequent catalytic hydrogénation provided anhydride 
148 in an overall yield of 64%. As in the previous cases, methanolysis 
of anhydride M8 furnished acid 1^  in quantitative yield. Treatment 
of acid with trifluoroacetic anhydride afforded the chromato-
graphically unstable trifluoroacetate 150, which was hydrolyzed with 
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potassium cyanide to the hydroxyester 151. The overall yield for this 
cyclization-hydrolysis sequence was 74%. The trans-stereochemistry 
of the hydroxyl and carbomethoxyl groups is supported again by proton 
NMR. 
143 
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Having successfully constructed the tetracyclic skeleton of the 
anthracyclines, we directed our attention to the functionalization of 
hydroxyester 151. We had envisioned the introduction of the C-9 ethyl 
sidechain by a Grignard reaction on the corresponding ketoester. 
Smith and Leuenberg have investigated the oxidation of g-hydroxyesters 
(105) and have reported that the Swern oxidation gave good to excellent 
yields of the ketoesters. Furthermore, oxidation with pyridinium 
chlorochromate, 2,3-dichloro-5,6-dicyanobenzoquinone, Jones' reagent, 
48 
and manganese dioxide gave poor results due to the g-elimination of 
water and the competitive oxidation of the resulting enol. Swern 
oxidation of hydroxyester 151 resulted in the formation of an 
unidentifiable purple oil. Because this failure may have resulted 
from the oxidation of the phenolic B ring, we decided to protect the 
phenolic hydroxyl as the methyl ether. 
Attempted methylation with dimethylsulfate and potassium carbonate 
failed to give the desired product. Since the C-11 phenolic hydroxyl 
is highly chelated, attempts to methylate it with silver (I) oxide and 
methyl iodide (106) were tried; however, only starting material was 
obtained. An attempt to methylate the phenolic hydroxyl with diazo-
methane (107) also failed. Because the C-11 phenolic hydroxyl was 
reluctant to methylate, we had to reexamine the possibility of oxidizing 
hydroxyester ^ 51 without protection. 
Jung and Brown have reported the selective oxidation of secondary 
alcohols in the presence of primary alcohols with trityl tetrafluoroborate 
(108). Due to the bulkiness of this reagent, we anticipated that it 
would not interact with the C-11 hydroxyl group. This proved to be 
the case; however, only starting material was isolated from the 
reaction. A final attempt to oxidize hydroxyester 151 with N,N'-di-
cyclohexylcarbodiimide and ortho-phosphoric acid in dimethylsulfoxide 
was tried. Although this oxidation gave good results for the oxidation 
of 3-hydroxyesters in indole alkaloids (109), only starting material 
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was obtained with hydroxyester 151. With the failure to oxidize 
hydroxyester 151, the C-9 ethyl sidechain must be introduced at the 
furan stage of the synthesis. 
Since hydroxyester _^ 1 was formed rapidly and efficiently, we 
decided to transform hydroxyester into a 9-dealkyl anthracyclinone. 
Oxidative demethylation (110) of hydroxyester ^ 1 gave an inseparable 
mixture of anthraquinones 152 and ^ 3. Formation of this mixture is 
supported by the three phenolic hydroxyl peaks in the proton NMR and 
by the molecular ion peaks (368 and 352 m/e) in the mass spectrum. 
Attempts to convert hydroxyester 151 directly into anthraquinone 153 
by varying the temperature of the reaction and the equivalents of 
silver (II) oxide (111) failed. Since attempts to convert this mixture 
to anthraquinone 153 by resubmitting it to the oxidation condition also 
failed, formation of anthraquinone 133 presumably results from the 
oxidation of the B ring prior to the C ring. Because Boeckman and 
coworkers have recently reported the transformation of a 6-deoxy-
anthraquinone to the 6-hydroxyanthraquinone (112), the mixture of 
anthraquinones 1% and 153 could be converted to anthraquinone 153. 
151 
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However, we believed a more rapid and efficient approach to 
anthraquinone ^ 3 could be accomplished by the oxidation of hydroxy-
ester 151 to anthraquinone ^ 4. Oxidative demethylation and reductive 
work-up would provide anthraquinone ^ 3. A similar approach has been 
used by Mauser and Prasanna (113). Due to the highly chelated nature 
'of the C-ll hydroxyl group, attempts to oxidize hydroxyester 131 to 
anthraquinone ^ 4 with Fremy's salt (114) failed. Since thallium 
trinitrate (TTN) oxidizes phenols to the corresponding quinones by 
attacking the para-position (115), we anticipated the formation of 
H,C 0 0 E 
151 » DIX) 
H3CO 0 
154 E=C02CH3 
anthraquinone 154 with thallium trinitrate. However, oxidation of 
hydroxyester ^ 1 resulted in the unexpected formation of anthraquinone 
152 in 70% yield after recrystallization. With the formation of 
anthraquinone 152, which could be converted to anthraquinone 153, we 
directed our attention to the incorporation of the C-9 ethyl sidechain 
into our synthesis. 
H3CO HO E 
" t^OH I )  TTN 
H3CO 
2) H3O+ 
151 E = C02CH3 
» 01 la 
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Although 2-ethylfuran 155 is commercially available and would 
introduce the C-9 ethyl sidechain, we anticipated a decrease in the 
selectivity of the methanol addition. However, conversion of furan 156 
to naphthylfuran would allow for the selective formation of acid ^ 8 
via an intramolecular attack of the hydroxyl group. Furan 156 was 
prepared in 71% yield by the addition of ethylene oxide to 2-fury1 lithium. 
Protection of the primary alcohol with ethyl vinyl ether produced furan 
159 in excellent yield. Although similar furans have been metallated 
with two or three equivalents of n-butyllithium (116), all attempts 
to metallate furan 159 with one equivalent of n-butyllithium failed. 
Since we could not use a large excess of alkyl lithium due to the 
cuprate formation, furan 156 was converted to furan ^ 0 in the hope 
that metallation could be accomplished. However, furan 1^  could not 
be metallated. Attempts to prepare the dianion of furan ^ 6 also failed. 
With the failure to metallate furans 159 and 160, the naphthylfuran 
157 could not be formed via the cuprate coupling strategy. 
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Since furans can be formylated in excellent yields (117), we 
envisioned the formation of benzylfuran 162 from aldehyde 161 via the 
tandem alkylation-reduction sequence. Conversion of benzylfuran 162 
to lactone 163 and subsequent cycloaddition would produce the linear 
tetracyclic skeleton of the anthracyclines. 
Vilsmeier-Haack formylation (POCl^ /DMF) of furan 1^  afforded 
aldehyde li^  in 86% yield. Tandem alkylation-reduction of aldehyde 
161 with lithiated p-dimethoxybenzene produced a mixture of benzyl-
furans 162 and 164. Although benzylfuran 162 was formed only in trace 
RO 
RO 
RO HO 
RO 
162 R=CH3 163. 
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amounts, resubmitting the crude mixture to the same reduction conditions 
afforded benzylfuran 162 in an overall yield of 63%. The failure to • 
produce benzylfuran directly was attributed to the generation of the 
insoluble bisalkoxide salt of benzylfuran 1^ . This salt could be 
observed precipitating from the solution. Attempts to form benzyl­
furan ^ 2 directly by increasing the ratio of tetrahydrofuran and by 
adding a proton source (ethanol, t-butanol, and acetic acid) failed. 
Although benzylfuran 162 could not be formed directly, it could be 
produced in gram quantities by sequential reductions. 
RO I) n-BuLi 
2) m 
3) Li/NH, 
RO THF 
RO RO 
RO RO OH 
164 162 R=CH3 
Cycloaddition of benzylfuran 1^ 2 with maleic anhydride at ambient 
temperature and simple filtration of the reaction mixture afforded 
adduct ^  in 75% yield. Concentration of the filtrate resulted in a 
mixture of starting materials and ester Attempts to convert this 
mixture to adduct 1^  failed. Imagawa and coworkers have also reported 
the formation of a similar mixture and the failure of the intramolecular 
cyclization (118). 
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RO HO 0^ 0 RO 0^^  
RO O^OH RO 
R — C  H g  165 166 
Hydrogénation of adduct ]£5 gave acid 1^  in 80% yield after 
recrystallization. Due to the insolubility of acid ^ 7, it was 
characterized as the methyl ester. While treatment of acid 1£7 with 
trifluoroacetic anhydride for short reaction times (6 hrs) afforded 
starting material, longer reaction times (18 hrs) resulted in the 
decomposition of the starting material. However, acid 167 could be 
cyclized by treating the mixed anhydride (formed from TFAA) with tin 
tetrachloride (119). Using this reaction sequence, ketolactone 168 
was isolated in 85% yield. 
2) SnCl4 
1} TFAA 
RO 0 
RO RO 
R=CH3 167 168 
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Since the cyclization of acid 167 produced ketolactone 168 
instead of the desired lactone 163, we investigated the transformation 
of the ketolactone into lactone 163. As in the case of the hydroxy-
esters 136 and 151, we anticipated the aromatization of ketolactone 
168 with trifluoroacetic acid. However, treatment of ketolactone 1^  
with trifluoroacetic acid resulted in either the isolation or de­
composition of the starting material. This result explains why 
cyclization with trifluoroacetic anhydride could not be accomplished. 
Since Lewis acids can enolize carbonyls, we decided to attempt the 
aromatization with Lewis acids. Treatment of ketolactone ^ 8 with boron 
trifluoride etherate afforded lactone 169 in 67% yield. Although the 
aromatization also resulted in the elimination of the g-hydroxyl group, 
introduction of the g-hydroxyl via epoxidation and reduction has been 
reported (45). 
RO HO 0 HO RO 
BF.-C&p Ago 
ÇOO' HNO3 
RO 
R=CH3 i69 
0 HO RO 0 
Oxidative demethylation of lactone 1^  produced a mixture of 
quinones 170 and 171. This mixture proved difficult to separate and 
could only be partially resolved. Attempts to form quinone 
selectively by varying the reaction temperature and the equivalents of 
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silver (II) oxide failed. Due to the formation of quinones 170 and 
171, we decided to prepare ketoquinone 172 from ketolactone 1^ . 
Oxidative demethylation of ketolactone 168 afforded ketoquinone 172; 
however, it proved difficult to purify and was used without purification. 
Cycloaddition of ketoquinone n2 with l-acetoxy-l,3-butadiene in 
refluxing benzene resulted in the formation of a complex mixture. 
The formation of these mixtures is due to the instability of keto­
quinone 172, instability which has been observed in similar systems (120). 
While this work was in progress, John Walling had successfully de-
oxygenated diaryl carbinols with sodium borohydride and boron tri-
fluoride etherate in diglyme (121). Anticipating the formation of 
naphthylfuran 157 from this reaction, we focused our attention on 
the synthesis of naphthylfuran 1^ . 
Metallation of 2-bromo-l,4-dimethoxynaphthalene 1^  in diethyl 
ether at -78°C and addition of aldehyde 161 afforded furyl alcohol 
173. Due to the extreme instability of furyl alcohol 173, the 
concentrated alcohol was immediately diluted with dry tetrahydrofuran 
and was reduced with sodium borohydride and boron trifluoride etherate 
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to produce naphthylfuran jJA. The formation of naphthylfuran 174 
was very erratic, with yields ranging from 48% to 61%. 
NaBH^  
BFg" OEtg 
Since naphthylfuran ^ 4 failed to react with maleic anhydride, 
the benzyl ether was hydrolyzed to produce naphthylfuran 157 in 93% 
yield. Cycloaddition of naphthylfuran with maleic anhydride 
afforded adduct 175 in 60% yield. As in the cycloaddition of benzyl-
furan 1^ , concentration of the filtrate resulted in a mixture of 
starting materials and ester 176. While this mixture could not be 
converted to adduct 175, it could be converted to naphthylfuran 1^  
by refluxing with lithium hydroxide in methanol. Thus, the overall 
yield of adduct ]J5 based on recovered naphthylfuran was 81%. 
RO RO 
O 
I) n— BuLi 
Br 2) 161 
RO 
141 
b^ Ph 
RO OH 
73 
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Hydrogénation of crude adduct 175 afforded acid in 95% yield. 
Both proton and carbon NMR indicated a mixture of diastereomers; however, 
the ratio of this mixture was greater than 10:1. Because attempts to 
recrystallize acid 158 produced an oil, the crude solid was used 
without purification. Cyclization of acid with trifluoroacetic 
anhydride/tin tetrachloride gave ketolactone 177. Recrystallization 
of the crude ketolactone afforded a single diastereomer in 75% 
yield. This diastereomer was highly crystalline (monoclinical) and has 
been submitted for a single crystal X-ray determination. 
I) TFAA 
While aromatization of ketolactone 1^  was accomplished with boron 
trifluoride etherate, treatment of ketolactone ]T7 with this Lewis 
acid resulted in the formation of a complex mixture which could not be 
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separated. In the hope that aromatization could be accomplished with 
a trifluoroacetic acid/trifluoroacetic anhydride mixture, we attempted 
this aromatization; however, only decomposition products were isolated. 
As a result of these initial failures, we anticipated a more facile 
aromatization could occur by the enolization of ketoquinone 178. 
Oxidative demethylation of ketolactone 177 produced ketoquinone 178, 
which when dissolved in deuterated chloroform afforded a red precipitate. 
This precipitate was shown to be the anthraquinone 179. Treatment of 
the crude ketoquinone 178 with a catalytic amount of concentrated 
hydrochloric acid precipitated anthraquinone 179 in extremely poor 
yield (20%). Concentration of the filtrate afforded an unidentifiable 
material. Attempts to aromatize ketoquinone 178 with acetic acid also 
produced anthraquinone 179, but in lower yields. 
The sequential Diels-Alder/Friedel-Crafts strategy has afforded 
a rapid route to the anthracycline skeleton. However, this strategy 
is plagued by the poor conversion of ketolactone 177 to anthraquinone 
179. The reason for this poor conversion is not obvious. Due to this 
poor conversion, other strategies for aromatization must be tried. 
One such strategy is the benzylic oxidation of ketolactone 177 with 
1 7 8  1 7 9  
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2,3-ciichloro-5,6-clicyanobenzoquinone (122), which would produce 
diketone 180. Cleavage of the carbon-oxygen bond should occur easily 
with zinc in acetic acid (123). This strategy would also introduce the 
C-6 hydroxyl group. Since boron trifluoride etherate is only capable of 
monodentate coordination, the use of a bidentate Lewis acid (TiCl^  or 
SnCl^ ) may provide more selectivity in the aromatization and represents 
a second possibility. Aromatization of ketolactone 177 under basic 
conditions may also be possible. 
RO 
1 7 7  R=CH3 
RO 0 
180 
61 
CONCLUSION 
The sequential Diels-Alder/Friedel-Crafts strategy has proven to 
be an effective approach for the expedient formation of anthracycline 
intermediates. While anthraquinone 151 can be formed in only 8 steps 
in an overall yield of 16%, ketolactone 177 can be formed in 7 steps in 
an overall yield of 25%. These syntheses are extremely short, proceed 
in good yield, use inexpensive starting materials, and produce highly 
functionalized intermediates. Moreover, anthraquinone 151 and keto­
lactone 177 are generated from a common starting material. This 
approach is also very versatile. Use of napthalenes 145 and 1^  or 
aldehyde ^ 2 would allow for the rapid formation of several novel 
anthracycline analogues. 
HO ÇO2CH3 
1 7 7  
R=CH, 
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RO 
Br 
RO OR 
145, 
RO OR 
RO 
181 
hHK( 
182 
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EXPERIMENTAL 
General 
Unless otherwise noted, materials were obtained from commercial 
suppliers and were used without purification. Tetrahydrofuran and 
diethyl ether were distilled from lithium aluminium hydride prior to 
usage. Dichloromethane was distilled from phosphorus pentoxide. 
All reactions were conducted under a nitrogen atmosphere, and all 
extracts were dried over anhydrous sodium sulfate. Melting points were 
determined on a Fisher-Johns melting point apparatus and are uncorrected. 
Infrared spectra were obtained on a Beckman IR-4250 or Acculab 2 spectro­
meter. Nuclear magnetic resonance spectra were determined on a Varian 
EM-360 spectrometer. High field (300 MHz) proton spectra were obtained 
using a Nicolet Magnetics Corporation NMC-1280 spectrometer. All 
chemical shifts are reported in 6 relative to tetramethylsilane as an 
internal standard. Carbon-13 NMR spectra were determined on a JOEL 
FX-90Q or Nicolet NMC-1280 spectrometer and are reported in ppm relative 
to the central peak of CDCl^  (77.06 ppm). High resolution mass spectra 
were recorded on a AEI-MS 902 high resolution mass spectrometer. Low 
resolution mass spectra were recorded on a Finnegan 4023 mass spectro­
meter. Elemental analyses were determined by Galbraith Laboratories, Inc. 
1-(2,5-Dimethoxyphenyl)-l-methoxyhexa-2,4-diene 1^  
To a solution of 1,4-dimethoxybenzene (3.00 g, 21.7 mmol) in 15 ml 
of ether at 0°C was added n-butyllithium (22 mmol). The solution was 
allowed to warm to room temperature and was stirred for 24 hrs. The 
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solution was cooled to -78°C and distilled 2,4-hexadienal (2.39 ml, 
21.7 mmol) in 10 ml of ether was added. The reaction was warmed to room 
temperature and was quenched with water. The aqueous phase was extracted 
three times with ether. The extracts were combined, washed with water 
and brine, dried, and concentrated to afford crude ^ 0 as a yellow oil. 
IMMR (CDClj) 5 1.82 (d, 3 H, J = 6 Hz), 3.70 (s, 6 H), 5.21 - 6.30 (m, 
5 H), 6.68 - 6.82 (m, 3 H). IR (film) 3440, 3010, 2950, 2820, 1600, 
1495, 1460, 1270, 1220, 1175, 1040, 985 cm"^ . 
To a suspension of sodium hydride (30 mmol) in 15 ml of THF at 
0°C was added crude ^ 0 in 20 ml of THF. The mixture was stirred for 
20 minutes. Methyl iodide (30 mmol) was added, and the mixture was 
stirred at room temperature for 7 hrs. The reaction was poured into 
ice water and the aqueous phase was extracted three times with ether. 
The extracts were combined, washed with water and brine, dried, and 
concentrated. The residue was chromatographed on silica gel using 6:1 
hexane/ether to yield 4.10 g (76%) of as a colorless oil. NMR 
(CDCl^ ) 6 1.82 (d, 3 H, J = 6 Hz), 3.30 (s, 3 H), 3.74 (s, 6 H), 5.05 
(d, 1 H, J = 6 Hz), 5.40 - 6.30 (m, 4 H), 6.68 - 6.83 (m, 2 H), 6.88 -
7.00 (m, 1 H). C-13 NMR 18.01, 55.73, 56.25, 56.38, 77.32, 112.05, 
112.50, 113.28, 129.54, 130.39, 130.91, 131.10, 131.30, 151.07, 154.06 
ppm. IR (film) 3010, 2980, 2840, 1500, 1460, 1275, 1215, 1080, 1045, 
990 cm'l. 
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4-[(2,5-Dimethoxypheny1)methoxymethyl]-7-methy1-4,7,8,9-tetrahydroiso-
benzofuran-l,3-dione 
To a solution of 121 (1.45 g, 5.85 mmol) in 5 ml of ether was 
added maleic anhydride (0.57 g, 5.85 mmol). The flask was sealed with 
a septum and the reaction was stirred for 24 hrs. The solid was 
filtered, washed with 4:1 hexane/ether, and dried in vacuo. Recrystall-
ization from acetone/hexane yielded 1.53 g (77%) of 122 (mp 153 - 155°C). 
NMR (CDCl,) 6 1.35 (d, 3 H, J = 7 Hz), 2.23 - 2.78 (m, 4 H), 3.22 (s, 
3 H), 3.76 (S, 3 H), 3.82 (s, 3 H), 5.30 (d, 1 H, J = 11 Hz), 6.63 
(br s, 2 H), 6.78 - 6.90 (m, 3 H). C-13 NMR 16.32, 30.76, 43.18, 
43.64, 45.91, 55.73, 56.19, 56.38, 74.46, 112.11, 113.35, 113.80, 
129.61, 129.80, 134.61, 152.37, 154.25, 171.49, 171.81 ppm. IR (CDCl^ ) 
3010, 2940, 2840, 1850, 1775, 1500, 1460, 1275, 1260, 1045, 950, 
925 cm~^ . Elemental analysis calculated for 65.88; 
H, 6.40. Found: C, 65.65; H, 6.64. 
7-Carbomethoxy-3-(2,5-dimethoxyphenyl)-6-methyl-3a,6,7,7a-tetrahydro-3H-
isobenzofuran-l-one 123 
To a solution of 122 (0.346 g, 1 mmol) in 5 ml of dichloromethane 
at 0°C was added tin tetrachloride (0.35 ml, 3 mmol). The solution 
was stirred for 1 hr at 0^ 0. The reaction was poured into ice water 
and was extracted three times with dichloromethane. The extracts were 
combined, washed with water, dried, and concentrated. Recrystallization 
from acetone/hexane yielded 0.266 g (79%) of 1^  (mp 128 - 130°C). NMR 
(CDCl^ ) S 1.20 (d, 3 H, J = 7 Hz), 2.95 - 3.30 (m, 4 H), 3.70 (s, 3 H), 
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3.78 (s, 3 H), 3.85 (s, 3 H), 5.00 - 5.80 (m, 3 H), 6.72 (br s, 3 H). 
C-13 NMR 18.08, 33.62, 35.51, 42.33, 44.61, 52.22, 55.67, 55.80, 
75.63, 110.88, 113.02, 113.61, 123.69, 126.74, 134.48, 149.24, 153.34, 
169.34, 172.85 ppm. IR (CDCl^ ) 3005, 2960, 2850, 1770, 1740, 1500, 
1465, 1360, 1275, 1220, 1050 cm~^ . Elemental analysis calculated for 
1^9^ 22°6* 65.88; H, 6.40. Found: C, 66.06; H, 6.34. 
4,5-Dicarboxy-3-[(2,5-dimethoxyphenyi)methyl]-6-methylcyclohex-i-ene 125 
To a solution of 122 (0.547 g, 1.60 mmol) in 2 ml of THF was added 
4 ml of IN KOH. The reaction was stirred for 3 hrs at room temperature. 
The reaction mixture was diluted with 20 ml of benzene and was 
concentrated ^  vacuo. This process was repeated three times. The crude 
solid was suspended in 10 ml of THF. Approximately 20 ml of liquid 
ammonia was then added. Small pieces of lithium wire (3.5 mmol) were 
added, and the reaction was stirred for 15 minutes. The reaction was 
quenched with solid ammonium chloride, and the ammonia was allowed to 
evaporate. The residue was partitioned between brine and ether, was 
acidified with 6N HCl, and extracted with ether two times. The extracts 
were combined, dried, and concentrated to yield 0.483 g (89%) of 125 
(mp 173 - 176°C). NMR (CDCl^ ) 6 1.12 (d, 3 H, J = 7 Hz), 2.50 - 3.20 
(m, 6 H), 3.75 (s, 6 H), 5.55 (br s, 2 H), 6.70 (s, 3 H), 9.40 (br s, 
2 H). IR (CDCI3) 3400 - 2450 (br) 1720, 1500, 1465, 1430, 1280, 1225, 
1045 cm"^ . 
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A-[(2,5-Dimethoxyphenyl)methoxymethy1]-7-methyl-3a,4,7,7a-tetrahydro-
isobenzofuran-l,3-dione 126 
To a solution of ^ 5 (1.39 g, 4.16 mmol) in 10 ml of dichloro-
methane was added 0.75 ml of trifluoroacetic anhydride (5.2 mmol) at G°C. 
After stirring for 6 hrs at room temperature, the reaction was concentrated 
in vacuo. Recrystallization from acetone/hexane yielded 0.918 g (70%) 
of 1^  (mp 167 - 168°C). NMR (CDCl?) 6 1.35 (d, 3 H, J = 7 Hz), 3.05 -
3.40 (m, 6 H), 3.76 (s, 6 H), 5.65 - 5.90 (m, 2 H), 6.73 (s, 2 H), 
6.90 (br s, 1 H). C-13 NMR 16.26, 30.56, 31.54, 35.96, 44.87, 46.24, 
55.67, 55.80, 111.40, 111.98, 117.51, 128.89, 133.77, 134.09, 151.98, 
153.47, 171.29, 172.01 ppm. IR (CDCl^ ) 2940, 2840, 1850, 1775, 1500, 
1465, 1225, 1040 cm~^ . Elemental analysis calculated for Cj^ gH2Q0^ : 
C, 68.34; H, 6.37. Found: C, 67.91; H, 6.16. 
l-Carbomethoxy-5,8-dimethoxy-2-methy1-9-oxo-l,2,4a,9,9a,10-hexahydro-
anthracene 127 
To a solution of 126 (0.130 g, 0.41 mmol) in 3 ml of dichloro-
methane at 0°C was added aluminum chloride (0.134 g, 1.0 mmol) in small 
portions. After stirring for 8 hrs at 0°C, the reaction mixture was 
poured into ice water. The aqueous phase was extracted three times with 
dichloromethane. The extracts were combined, washed with water, dried, 
and concentrated. The crude solid was dissolved in dichloromethane 
and esterified with diazomethane. The reaction mixture was concentrated 
and chromatographed on silica gel using 1:1 hexane/ether (10% CHgClg) as 
the solvent. Chromatography yielded 0.112 g (82%) of 127 (mp 117 -
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119°C). NMR (CDClg) 5 1.13 (d, 3 H, J = 7 Hz), 2.90 (br s, 3 H), 3.18 
(m, 3 H), 3.48 (s, 3 H), 3.65 (s, 3 H), 3.73 (s, 3 H), 5.48 (br s, 2 H), 
6.65 (d, 1 H, J = 8 Hz), 6.88 (d, 1 H, J = 8 Hz). C-13 NMR 18.47, 
26.40, 31.54, 33.30, 45.00, 48.25, 50.98, 56.32, 110.10, 116.08, 123.56, 
128.56, 132.53, 133.57, 149.96, 153.67, 173.24, 197.43 ppm. IR (CDCl^ ) 
3015, 2960, 2850, 1745, 1660, 1495, 1460, 1263, 1200, 1090, 1030 cm"^ . 
MS (m/e) 330, 315, 298, 283, 271, 255, 230, 217, 178, 151. 
2- [ ( 2,5-Diniethoxy pheny 1 ) methyl ] fur an 128 
To a solution of 1,4-dimethoxybenzene (2.00 g, 14.6 mmol) in 10 ml 
of ether at 0°C was added n-butyllithium (14.9 mmol). After warming 
to room temperature, the solution was stirred for 24 hrs. The solution 
was then cooled to -78°C and distilled furfural (1.20 ml, 14.5 mol) in 
10 ml of THF was added. The yellow solution was stirred at -78°C 
for 15 minutes. Approximately 30 ml of liquid ammonia was then added 
followed by small pieces of lithium wire (32 mmol). The reaction was 
stirred for 30 minutes. Solid ammonium chloride was added, and the 
ammonia was allowed to evaporate. The residue was partitioned between 
ether and brine. The organic phase was dried and concentrated. The 
yellow oil was chromatographed on silica gel using 2:1 hexane/dichloro-
methane as solvent. Chromatography afforded 2.15 g (68%) of 128 as a 
colorless oil. NMR (CDCl^ ) 6 3.74 (s, 6 H), 3.91 (s, 2 H), 5.91 (d, 
1 H, J = 3 Hz), 6.14 - 6.28 (m, 1 H), 6.58 - 6.80 (m, 3 H), 7.20 (d, 
1 H, J = 2 Hz). C-13 NMR 22.35, 55.45, 56.05, 106.06, 110.16, 111.62, 
114.58, 116.34, 127.91, 141.05, 151.45, 153.47, 154.12 ppm. IR (film) 
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3010, 2950, 2840, 1595, 1500, 1460, 1280, 1220, 1040, 800, 730 cm"^ . 
High resolution mass spectrum for requires 218.0943; measured 
218.0938. 
4-[(2,5-Dimethoxypheny1)methyl]-3a,4,7,7a-tetrahydro-4,7-epoxyiso-
benzQfuran-l,3-dione ^ 9 
To a solution of 1% (5.00 g, 22.9 mmol) in 20 ml of ether was 
added maleic anhydride (2.25 g, 22.9 mmol). The flask was sealed with 
a septum and was covered with tin foil. The solution was stirred for 
24 hrs, diluted with 10 ml of hexane, and filtered. The solid was 
washed with 4:1 hexane/ether and dried in vacuo to yield 6.16 g (85%) 
of 129. NMR (CDCl,) 6 3.09 - 3.35 (m, 4 H), 3.72 (s, 3 H), 3.78 (s, 
3 H), 5.27 (br s, 1 H), 6.28 (br s, 2 H), 6.63 - 7.02 (m, 3 H). IR 
(CDClj) 1855, 1785, 1500, 1465, 1280, 1230, 1090, 1050 cm"^ . 
4-[(2,5-Dimethoxypheny1)methyl]hexahydro-4,7-epoxyisobenzo furan-1,3-
dione ^ 0 
To a suspension of activated 10% Pd/C (0.60 g) in acetone (15 ml) 
under a hydrogen atmosphere was added the crude 129 (6.16 g, 19.5 mmol) 
in 40 ml of acetone. The suspension was stirred for 6 hrs, filtered 
through celite, and concentrated in vacuo. The residue was filtered 
through a small column of silica gel using 1:1 hexane/dichloromethane 
solution and was recrystallized from hexane/dichloromethane to yield 
5.14 g (83%) of 130 (mp 160 - 162°C). NMR (CDCl^ ) 6 1.20 - 1.90 (m, 
4 H), 3.19 (s, 3 H), 3.33 (s, 1 H), 3.72 (s, 3 H), 3.74 (s, 3 H), 4.77 -
4.92 (m, 1 H), 6.71 (br s, 2 H), 6.90 - 7.02 (m, 1 H). C-13 NMR 29.46, 
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29.65, 30.89, 52.15, 52.87, 55.67, 55.99, 79.47, 89.74, 111.59, 112.83, 
117.77, 125.57, 151.91, 153.47, 170.05, 171.55 ppm. IR (CDCl^ ) 1875, 
1790, 1505, 1470, 1235, 1095, 1050 cm~^ . Elemental analysis calculated 
for C^ H^^ gOg: C, 64.14; H, 5.70. Found: C, 63.91; H, 5.75. 
l-Carbomethoxy-5,8-diinethoxy-9-oxo-l ,3,4,9,9a, 10-liexahydro-2H-2, 4a-epoxy-
anthracene JJl 
To a solution of 1:^  (0.102 g, 0.32 mmol) in 3 ml of dichloromethane 
at 0°C was added aluminum chloride (0.094 g, 0.704 mmol). The red 
suspension was stirred at 0°C for 2 hrs and at room temperature for 3 
hrs. The suspension was cooled to 0°C. Nitromethane (0.5 ml) which 
prevents the formation of an emulsion was added followed by 6N HCl 
(4 ml). The reaction was diluted with water and extracted with dichloro­
methane. The extracts were combined, washed with water, dried, and 
concentrated. The crude residue was dissolved in dichloromethane and 
esterified with diazomethane. Concentration and chromatography on silica 
gel using 2:1 ether/hexane (10% CH2CI2) yielded 0.036 g (35%) of (mp 
178 - I8IOC). NMR 5 1.58 - 1.90 (m, 4 H), 2.83 - 3.42 (m, 4 H), 3.57 
(s, 3 H), 3.76 (s, 3 H), 3.79 (s, 3 H), 4.58 (d, 1 H, J = 4 Hz), 6.75 
(d, 1 H, J = 9 Hz), 6.96 (d, 1 H, J = 9 Hz). C-13 NMR 26.08, 30.76, 
34.66, 51.96, 55.99, 56.45, 57.36, 79.14, 83.39, 111.01, 115.75, 123.43, 
129.80, 150.15, 153.47, 171.62, 196.52 ppm. IR (CDCl^ ) 1960, 1730, 
1675, 1590, 1480, 1435, 1265, 1070 cm"^ . MS (m/e) 332, 314, 301, 288, 
273, 255, 229, 216, 201, 177, 163, 115, 91, 77, 55. 
71 
2-Carboxy-3-carbornethoxy-l-[(2,5-dimethoxypheny1)methyl]-7-oxabicyclo-
[2.2.1]heptane 
A solution of 130 (1.00 g, 3.14 mmol) in 10 ml of dry methanol 
(dried with molecular sieves) was refluxed for 6 hrs. The solution was 
cooled to room temperature and was concentrated iji vacuo. The residue 
was dissolved in a sodium bicarbonate solution. The bicarbonate 
solution was washed with ether, acidified with 6N HCl, and extracted 
with dichloromethane. The extracts were combined, washed with water, 
dried, and concentrated to yield 1.08 g (98%) of 134 (mp 141 - 143°C). 
NMR (CDClj) Ô 1.32 - 1.72 (m, 4 H), 2.89 - 3.40 (m, 4 H), 3.64 (s, 3 H), 
3.72 (s, 6 H), 5.05 (br s, 1 H), 6.68 - 6.82 (m, 2 H), 6.96 (br s, 1 H), 
9.87 (br s, 1 H). C-13 NMR 30.04, 30.43, 31.54, 51.96, 53.32, 55.73, 
55.86, 56.58, 88.64, 111.40, 113.09, 117.31, 126.03, 151.78, 153.34, 
171.29, 176.23 ppm. IR (cdcl,) 3360 - 2930 (br), 1740, 1710, 1500, 
1465, 1435, 1225, 1050 cm~^ . Elemental analysis calculated for C^ gH220y: 
C, 61.71; H, 6.33. Found: C, 61.63; H, 6.30. 
trans-l-Carbomethoxy-2,9-dihydroxy-5,8-dimethoxy-l,2,3,4-tetrahydro-
anthracene 136 
To a solution of ^ 34 (0.350 g, 1 mmol) in 10 ml of dichloromethane 
at 0°C was added trifluoroacetic anhydride (0.29 ml, 2.05 mmol). The 
reaction was warmed to room temperature and was stirred 6 hrs. The 
reaction was then diluted with 30 ml carbon tetrachloride and concentrated 
in vacuo to afford crude 135. NMR (CDCl^ ) ô 1.94 - 2.45 (m, 2 H), 
2.97 - 3.28 (m, 2 H), 3.77 (s, 3 H), 3.95 (s, 3 H), 4.02 (s, 3 H), 
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4.60 (d, 1 H, J = 7 Hz), 5.28 - 5.70 (m, 1 H), 6.60 (s, 2 H), 7.58 (s, 
1 H), 9.87 (s, 1 H). IR (CDClj) 3460, 2980, 2860, 1790, 1740, 1640, 1615, 
1520, 1460, 1440, 1375, 1310, 1255, 1225, 1170, 1065 cm"^ . 
To a solution of crude 1^  in 10 ml of dry methanol was added 
several crystals of potassium cyanide. After stirring for 6 hrs at 
room temperature, the solution was neutralized with IN HCl and 
concentrated iji vacuo. The residue was dissolved in dichloromethane. 
The dichloromethane was washed with water, dried, and concentrated. 
The crude solid was filtered through a small column of silica gel using 
2:1 dichloromethane/ethyl acetate solution and was then recrystallized 
from dichloromethane/hexane to yield 0.246 g (74%) of 136 (mp 204 -
206°C). NMR (CDClj) 6 1.83 - 2.20 (m, 2 H), 2.90 - 3.28 (m, 2 H), 3.72 
(s, 3 H), 3.90 (s, 3 H), 3.98 (s, 3 H), 4.18 - 4.40 (m, 2 H), 6.54 
(s, 2 H), 7.50 (s, 1 H), 9.78 (s, 1 H). C-13 NMR 27.83, 28.03, 46.30, 
52.15, 55.73, 56.19, 68.48, 102.29, 102.81, 111.85, 127.26, 135.98, 
149.83, 152.11, 173.89 ppm. IR (CDCl^ ) 3540, 3300, 3060, 2955, 1735, 
1620, 1500, 1430, 1370, 1265, 1065 cm~^ . Elemental analysis calculated 
for CigHggOg: C, 65.08; H, 6.07. Found: C, 64.28; H, 6.01. 
Hydrolysis of trifluoroacetate via potassium carbonate was 
accomplished by adding the crude ]35 (1 mmol) to a degassed methanol/tetra-
hydrofuran (1:1) solution at 0°C. Potassium carbonate (2 mmol) was 
added. After stirring for 2 hrs at 0°C, the solution was neutralized 
and concentrated. The residue was dissolved in dichloromethane. The 
dichloromethane was washed with water, dried, and concentrated. 
Chromatography afford 0.167 g (50%) of 136. 
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2-[ ( 2,5-Diniethoxyphenyl ) methoxymethy 1 ] f uran 138 
Alcohol 1^  was prepared from p-dimethoxybenzene (4.00 g, 29 mmol) 
and distilled furfural (2.40 ml, 29 mmol) using the procedure developed 
for 1^ . NMR (CDCl^ ) 5 3.72 (s, 6 H), 5.88 - 6.27 (m, 3 H), 6.75 
(S, 2 H), 6.82 - 6.93 (m, 1 H), 7.21 - 7.35 (m, 1 H). IR (film) 3450, 
2960, 2840, 1500, 1465, 1377, 1240, 1180, 1150, 1040, 820, 740 cm"^ . 
Methylation of crude using the procedure developed for ^ 1 
afforded 138. Crude 138 was filtered through silica gel using 1:1 ether/-
hexane and was then recrystallized from ether/hexane to yield 4.94 g 
(69%) of 138 (mp 62 - 63°C). NMR (CDCl,) 6 3.36 (s, 3 H), 3.70 (s, 
3 H), 3.78 (s, 3 H), 5.60 (s, 1 H), 5.98 (d, 1 H, J = 4 Hz), 6.13 -
6.28 (m, 1 H), 6.74 (d, 2 H, J = 3 Hz), 7.04 - 7.17 (m, 1 H), 7.27 -
7.35 (m, 1 H). C-13 NMR 55.73, 56.32, 56.97, 72.31, 108.01, 110,03, 
112.05, 113.15, 113.93, 128.56, 142.35, 151.20, 153.99, 154.32 ppm. 
IR (CDClj) 3040, 2950, 2850, 1500, 1465, 1280, 1240, 1080, 1050 cm"^ . 
4-[(2,5-Dimethoxyphenyl)methoxymethy1]hexahydro-4,7-epoxyisobenzo-
furan-l,3-dione 139 
Cycloaddition of 138 (1.50 g, 6.05 mmol) with maleic anhydride 
(0.59 g, 6.04 mmol) was accomplished using the procedure developed for 
129. The crude solid was immediately hydrogenated using the procedure 
developed for 130. The crude 139 was chromatographed on silica gel 
using 1:1 ether/hexane (10% CHg^ lg) as solvent to yield 1.22 g (58%) of 
139 as a mixture of diastereomers (mp 122 - 1470C). NMR (CDCl^ ) 6 
1.52 - 1.98 (m, 4 H), 3.31 - 3.35 (br s, 5 H), 3.80 and 3.85 (two s. 
74 
6 H), 4.78 - 4.93 (m, 1 H), 5.12 and 5.27 (two s, 1 H), 6.73 - 6.84 
(m, 2 H), 7.07 - 7.28 (m, 1 H). IR (CDCl,) 2940, 2820, 1855, 1770, 
1487, 1455, 1257, 1210, 1080, 1035 cm~^ . Elemental analysis calculated 
for C^ gNggOy: C, 62.06; H, 5.79. Found: C, 61.60; H, 5.80. 
7-Carbomethoxy-3-(2,5-dimethoxypheny1)-6-methylhexahydro-3H-3a,6-epoxy-
isobenzofuran-l-one MO 
Using the methanolysis conditions of 134, anhydride 139 was converted 
to the carbomethoxyacid in quantitative yield (mp 70 - 89°C). NMR 
(CDClj) 6 1.40 - 2.06 (m, 4 H), 3.25 - 3.49 (m, 4 H), 3.64 - 3.79 
(m, 10 H), 4.57 - 4.76 (m, 1 H), 5.06 and 5.23 (two s, 1 H), 6.74 -
6.89 (m, 2 H), 7.04 - 7.20 (m, 1 H), 8.88 (br s, 1 H). IR (CDOl^ ) 
3400 - 2820 (br), 1740, 1705, 1490, 1455, 1425, 1270, 1240, 1210, 
1165, 1080, 1035 cm~^ . Elemental analysis calculated for C^ çH2^ 0g: 
C, 59.99; H, 6.36. Found: C, 59.14; H, 6.38. 
Attempted cyclization of the carbomethoxyacid (0.217 g, 0.57 mmol) 
via the procedure developed for 136 resulted in the formation of 
lactone 1^ . The crude product was chromatographed on silica gel using 
1:1:1 dichloromethane/ether/hexane as solvent. Chromatography afforded 
0.149 g (75%) of MO as a viscous oil. NMR (CDCl^ ) 5 1.43 - 2.00 (m, 
4 H), 3.02 (s, 1 H), 3.26 - 3.85 (m, 10 H), 5.00 - 5.19 (m, 2 H), 6.71 -
6.85 (m, 2 H), 6.90 - 7.04 (m, 1 H). IR (CDCl^ ) 3005, 2970, 2930, 
1785, 1740, 1500, 1470, 1435, 1250, 1220, 1155, 1040 cm~^ . MS (m/e) 
348, 330, 302, 271, 257, 225, 181, 165, 151, 113. 
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2-[ (5,8-Dihyciro-l ,A-diniethoxy-2-naphthalenyl)methyl]furan 142 
To a solution of 2-bromo-l,4-dimethoxynaphthylene (97) (1.10 g, 
4.14 mmol) in 5 ml of THF at -78°C was added n-butyllithium (4.20 
mmol). After stirring for 10 minutes, furfural (0.34 ml, 4.14 mmol) 
was added in 10 ml of THF, The reaction mixture was stirred for an 
additional 30 minutes. Approximately 50 ml of liquid ammonia was added 
followed by lithium wire (16.6 mmol). The reaction mixture was stirred 
for 30 minutes, solid ammonium chloride was added, and the ammonia 
was allowed to evaporate. The residue was partitioned between ether 
and brine. The organic phase was dried, filtered, and concentrated 
in vacuo. Chromatography using 2:1 hexane/dichloromethane provided 
0.61 g (54%) of U2 as a colorless oil. NMR (CDCl^ ) 6 3.28 (br s, 4 H), 
3.67 (s, 3 H), 3.72 (s, 3 H), 4.00 (s, 2 H), 5.84 - 6.05 (m, 3 H), 
6.20 - 6.34 (m, 1 H), 6.55 (s, 1 H), 7.22 (br s, 1 H). IR (film) 3040, 
2945, 2850, 1600, 1480, 1460, 1428, 1340, 1230, 1105, 1080, 1010 cm"^ . 
2-[(1,4-Dimethoxy-2-naphthaleny1)methyl]furan 1^  
a. Method A To a solution of 142 (0.50 g, 1.85 mmol) in 15 ml of 
benzene was added 3,4-dichloro-5,6-dicyano-l,4-benzoquinone (0.42 g, 
1.86 mmol). The dark red solution was refluxed for 20 hrs and was then 
filtered. The filtrate was diluted with ether, washed with IN NaOH, 
water, and brine, dried, and concentrated. Chromatography using 2:1 
hexane/dichloromethane afforded 0.247 g (50%) of 143 as a colorless oil. 
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b. Method B To a solution of furan (5.70 ml, 78.5 mmol) in 50 ml 
of ether at 0°C was added n-butyllithium (78.5 mmol). The solution 
was stirred for 1 hr at room temperature. The precipitated 2-furyl 
lithium was dissolved with 15 ml of THF. The solution was then 
transferred by a cannula to a suspension of cuprous iodide (7.50 g, 
39.5 mmol) in 50 ml THF at 0°C. After the addition of dimethyl sulfide 
(6.0 ml, 81 mmol), the dark solution was stirred for 30 minutes at 
0°C. A solution of 2-chloromethyl-l,4-dimethoxynaphthalene (2.87 g, 
12.2 mmol) in 20 ml of THF was added and the reaction was allowed to 
warm slowly to room temperature. The reaction was protected from light 
with tin foil and was stirred for 18 hrs. The reaction mixture was 
poured into ammonium chloride and extracted with ether. The extracts 
were combined, washed with brine, dried, filtered, and concentrated. 
The crude product was chromatographed on silica gel using 4:1 hexane/-
dichloromethane to afford 3.56 g (80%) of 143 as a colorless oil. 
NMR (CDClj) 5 3.89 (s, 6 H), 4.15 (s, 2 H), 6.00 (d, 1 H, J = 3 Hz), 
6.20 - 6.34 (m, 1 H), 6.64 (s, 1 H), 7.30 - 7.58 (m, 3 H), 7.92 - 8.33 
(m, 2 H). C-13 NMR 28.61, 55.54, 62.23, 105.54, 106.26, 110.29, 
121.87, 122.32, 125.12, 125.77, 126.55, 128.63, 141.38, 147.10, 151.85, 
154.51 ppm. IR (CDCl ) 3005, 2975, 2850, 1600, 1520, 1465, 1370, 
1270, 1165, 1120, 1090, 1005 cm~^ . High resolution mass spectrum for 
1^7*^ 16^ 3 acquires 268.10995; measured 268.11091. 
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3-Bromo-1,4,5-trimethoxynaphthalene 
To a solution of 2-bromo-4,8-dimethoxynaphthol (103) (2.20 g, 
7.77 mmol) in 40 ml of acetone was added dimethyl sulfate (0.94 ml, 
10.0 mmol) and potassium carbonate (1.93 g, 14.0 mmol). The reaction 
mixture was refluxed for 24 hrs, filtered, and concentrated in vacuo. 
The crude product was chromatographed on silica gel using 3:1 hexane/-
dichloromethane as solvent to yield 2.10 g (91%) of 145 (mp 82 - 84°C). 
NMR (CDCI3) Ô 3.81 (S, 3 H), 3.88 (s, 3 H), 3.95 (s, 3 H), 6.73 -
6.94 (m, 2 H), 7.28 (t, 1 H, J = 8 Hz), 7.83 (d, 1 H, J = 8 Hz). 
IR (CDCl,) 3010, 2980, 2950, 2850, 1588, 1515, 1465, 1417, 1345, 1270, 
1080 cm"^ . MS (m/e) 298, 296, 283, 281, 202, 187, 174, 159, 129. 
2-Chloromethyl-l,4-dimethoxynaphthalene 1^  
Gaseous HCl was passed through a solution of 37% aqueous formalde­
hyde (3.0 ml) and concentrated HCl (1.4 ml) in 6.0 ml of dioxane for 
15 minutes. The rate of HCl gas was controlled so that the internal 
temperature of the solution was maintained between 55 - 60°C. A 
solution of 1,4-dimethoxynaphthalene (97) (4.00 g, 21.2 mmol) in 12 ml 
of dioxane was added over a 20 minute period. After the addition was 
complete, the gaseous HCl addition was stopped. The reaction was 
cooled to room temperature and was poured into ice water. The aqueous 
phase was extracted with ether. The extracts were combined, washed 
with water and brine, dried, filtered, and concentrated in vacuo. 
Chromatography on silica gel using 9:1 hexane/dichloromethane afforded 
3.22 g (64%) of 147 (mp 64 - 65°C). NMR (CDCl^ ) 5 3.96 (s, 6 H), 
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4.83 (s, 2 H), 6.75 (s, 1 H), 7.40 - 7.59 (m, 2 H), 7.96 - 8.32 (m, 
2 H). C-L3 NMR 41.42, 55.53, 62.88, 104.37, 122.13, 122.39, 125.25, 
126.03, 126.81, 128.30, 147.75, 152.10 ppm. IR (CDCl^ ) 3080, 2940, 
2850, 1630, 1600, 1515, 1460, 1370, 1270, 1225, 1160, 1125, 1095, 
1030, 1000 cm'l. 
4-[(1,4-Dimethoxy-2-naphthalenyl)methyl]hexahydro-4,7-epoxyisobenzo-
furan-l,3-dione 1^  
Cycloaddition of 143 (3.00 g, 11.2 mmol) with maleic anhydride 
(1.10 g, 11.2 mmol) in 9 ml of ether was accomplished using the procedure 
developed for 129. The precipitate was filtered and washed with 4:1 
hexane/ether to yield 2.99 g of crude product. NMR (CDCl^ ) 6 3.32 (s, 
3 H), 3.44 (s, 1 H), 3.94 (s, 6 H), 5.31 (br s, 1 H), 6.30 (br s, 2 H), 
6.89 (s, 1 H), 7.30 - 7.67 (m, 2 H), 7.95 - 9.33 (m, 2 H). IR (CDCl^ ) 
3080, 3005, 2940, 2840, 1850, 1780, 1625, 1593, 1458, 1365, 1260, 1225, 
1085, 995 cm'l. 
The crude product was hydrogenated using the procedure developed 
for ]^ . Chromatography and recrystallization afforded 2.64 g (overall 
yield of 64%) of ^  (mp 163 - 164°C). NMR (CDCl^ ) S 1.30 - 1.75 
(m, 4 H), 3.27 (s, 2 H), 3.52 (d, 2 H, J = 5 Hz), 3.88 (s, 3 H), 3.97 
(s, 3 H), 4.97 (br s, 1 H), 6.98 (s, 1 H), 7.34 - 7.60 (m, 2 H), 
7.88 - 8.27 (m, 2 H). C-13 NMR 29.52, 30.37, 31.08, 52.02, 53.13, 
55.73, 62.10, 79.73, 89.87, 106.65, 121.93, 122.39, 124.21, 125.31, 
126.03, 126.55, 128.30, 147.81, 151.65, 170.23, 171.49 ppm. IR (CDCl^ ) 
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3060, 2950, 2840, 1870, 1785, 1625, 1595, 1458, 1370, 1260, 1225, 
1085, 995, 935 cm~^ . Elemental analysis calculated for Cg^ HggOg: 
C, 68.47; H, 5.47. Found C, 68.47; H, 5.52. 
2-Carboxy-3-carbomethoxy-l-[(1,4-dimethoxy-2-naphthaleny1)methyl]-7-oxa-
bicyclo[2.2.1]heptane ^ 9 
Using the methanolysis conditions of 134, anhydride ^ 8 was 
converted to 149 in quantitative yield (mp 161 - 164°C). NMR (CDCl^ ) 
5 1.22 - 1.76 (m, 4 H), 3.00 - 3.43 (m, 4 H), 3.68 (s, 3 H), 3.79 (s, 
3 H), 3.93 (s, 3 H), 5.06 (br s, 1 H), 6.95 (s, 1 H), 7.38 - 7.60 (m, 
2 H), 7.72 - 8.25 (m, 2 H). C-13 NMR 29.78, 30.30, 31.41, 51.44, 52.48, 
55.54, 56.77, 61.58, 76.47, 87.99, 106.32, 106.65, 121.48, 121.87, 
124.53, 125.25, 125.96, 127.72, 147.03, 150.87, 171.49, 173.89 ppm. 
IR (CDClj) 3450 - 2430 (br), 1745, 1710, 1600, 1463, 1375, 1268, 1230, 
1090 cm~^ . Elemental analysis calculated for ^ 22^ 2407* C, 65.99; 
H, 6.04. Found: C, 65.74; H, 6.18. 
trans-l-Carboxy-2,12-dihydroxy-6,ll-dirrethoxy-l,2,3,4-tetrahydro-
naphthacene 151 
Using the cyclization conditions of 136,  acid 149 (0.817 g, 2.04 
mmol) was converted to 150 with trifluoroacetic anhydride (0.59 ml, 
4.18 mmol) in 20 ml dichloromethane. MHz 300, NMR (CDCl^ ) 6 2.09 -
2.21 (m, 1 H), 2.45 - 2.61 (m, 1 H), 3.08 - 3.29 (m, 1 H), 3.28 -
3.40 (m, 1 H), 3.76 (m, 3 H), 4.06 (s, 3 H), 4.07 (s, 3 H), 4.72 (d, 
1 H, J = 7 Hz), 5.51 - 5.58 (m, 1 H), 7.42 - 7.53 (m, 2 H), 7.61 (s. 
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1 H), 8.09 - 8.18 (m, 1 H), 8.22 - 8.30 (m, 1 H), 10.21 (s, 1 H). IR 
(CDCl^ ) 3555, 2960, 1785, 1735, 1640, 1450, 1365, 1220, 1160, 1045 
-1 
cm . 
Potassium cyanide/methanol hydrolysis of ^ 0 afforded 151. 
Chromatography on silica gel using 4:2:1 ether/hexane/dichloromethane 
yielded 0.576 g (74%) of 151 (mp 154 - 155°C). MHz 300, NMR (CDCl^ ) 
6 2.02 - 2.10 (m, 1 H), 2.16 - 2.27 (m, 1 H), 2.73 (br s, 1 H), 2.99 -
3.11 (m, 1 H), 3.28 - 3.37 (m, 1 H), 3.78 (s, 3 H), 4.07 (s, 3 H), 
4.09 (s, 3 H), 4.32 - 4.45 (m, 2 H), 7.43 - 7.50 (m, 2 H), 7.61 (s, 
1 H), 8.11 - 8.18 (m, 1 H), 8.21 - 8.27 (m, 1 H), 10.12 (s, 1 H). 
C-13 NMR 27.96, 28.22, 46.50, 52.09, 62.88, 64.31, 68.48, 111.59, 
114.26, 114.78, 121.67, 122.71, 123.17, 125.12, 125.31, 125.57, 135.46, 
147.42, 148.33, 151.33, 152.30, 173.76 ppm. IR (CDCl^ ) 3680 - 3260 
(br), 2950, 1730, 1650, 1435, 1360, 1350, 1190, 1165, 1045 cm"^ . 
Elemental analysis calculated for ^ 22^ 22^ 6' H, 5.80. 
Found: C, 66.89; H, 6.06. High resolution mass spectrum for ^ 22^ 22^ 6 
requires 382.14164; measured 382.14307. 
trans-Carbomethoxy-2,12-dihydroxy-l,2,3,4-tetrahydronaphthacene-6,11-
dione ^ 2 
a. Attempted preparation with silver (II) oxide/nitric acid To 
a solution of 151 (0.050 g, 0.13 mmol) in 2 ml of THF at room temperature 
was added silver (II) oxide (111) (0.064 g, 0.52 mmol). After the 
addition of 0.13 ml of 6N HNO^ , the reaction mixture was stirred for 
5 minutes. The reaction mixture was poured into water and extracted 
with dichloromethane. The extracts were combined, washed with water 
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and brine, dried, and concentrated in vacuo. Chromatography on silica 
gel using 2:2:1 hexane/ethyl acetate/dichloromethane provided a mixture 
of 152 and 1^  (0.034 g). NMR (CDCl,) ô 1.78 - 2.17 (m), 2.70 - 3.15 
(m), 3.76 (s), 4.12 - 4.40 (m), 7.50 - 8.42 (m), 13.10 (s), 13.33 (s), 
13.46 (s). IR (CDClj) 3600 - 3380 (br), 1725, 1690, 1585, 1350, 1270 
cm'l. MS (m/e) 368 (M+), 352 (M+), 308, 291, 275, 264. 
b. Preparation with thallium trinitrate To a solution of 
thallium (III) nitrate trihydrate (0.930 g, 2.09 mmol) in 3 ml of 
methanol at 0°C was added 151 (0.382 g, 1.00 mmol) in 7 ml of methanol. 
The reaction mixture was stirred for I hr at 0°C and was then filtered. 
The filtrate was concentrated vacuo, and the residue was dissolved 
in 10 ml of THF. After the addition of 2 ml IN HCl, the reaction was 
stirred for 10 hrs. The reaction was diluted with dichloromethane. 
The organic phase was washed with water, dried, and concentrated in 
vacuo. Recrystallization from hot methanol provided 0.246 g (70%) 
of ^ 2 (mp 259 - 262°C). MHz 300, NMR (CDCl^ ) 6 2.01 - 2.19 (m, 2 H), 
2.73 (br s, 1 H), 2.88 - 3.03 (m, 1 H), 3.14 - 3.27 (m, 1 H), 3.78 
(s, 3 H), 4.25 - 4.37 (m, 2 H), 7.64 (s, 1 H), 7.77 - 7.83 (m, 2 H), 
8.27 - 8.33 (m, 2 H), 13.14 (s, 1 H). C-13 NMR 27.07, 28.34, 45.86, 
52.22, 67.06, 113.30, 119.91, 126.72, 127.24, 128.69, 131.27, 133.20, 
133.55, 134.03, 134.42, 146.86, 161.20, 172.13, 182.31, 188.00 ppm. 
IR (CDCl^ ) 3540 - 3300 (br), 2940, 1725, 1650, 1345, 1050 cm~^ . UV 
(MeOH) 227, 246, 261, 327, 405 nm. Elemental analysis calculated for 
2^0^ 16°6* 68.18; H, 4.58. Found: C, 65.84; H, 5.08. High 
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resolution mass spectrum for €20^ 16^ 6 inquires 352.09469; measured 
352.09605. 
2-(2-Furyl)ethanol ^ 6 
To a solution of furan (10.0 ml, 137 mmol) in 100 ml of ether at 
0°C was added n-butyllithium (150 mmol). The reaction was stirred 
for 3 hrs at room temperature and was then cooled to 0°C. Ethylene 
oxide (10.0 ml, 200 mmol) was slowly added, and the reaction was 
stirred for 1 hr. The reaction mixture was poured into water and was 
then extracted with ether. The extracts were combined, washed with 
brine, dried, and concentrated in vacuo. Distillation afforded 10.86 g 
(71%) of 156 (bp 40°C, 3 mm Hg). NMR (CDCl^ ) 5 2.42 (br s, 1 H), 
2.87 (t, 2 H, J = 7 Hz), 3.85 (t, 2 H, J = 7 Hz), 6.10 (d, 1 H, J = 
4 Hz), 6.23 - 6.38 (m, 1 H), 7.29 - 7.40 (m, 1 H). C-13 NMR 31.41, 
60.74, 106.19, 110.09, 141.24, 152.82 ppm. IR (film) 3560 - 3100 (br), 
2900, 1585, 1490, 1130, 1030, 710 cm"^ . 
Ethyl vinyl ether of 2-(2-furyl)ethanol 159 
To a solution of 156 (14.54 g, 138 mmol) and ethyl vinyl ether 
(18.0 ml, 188 mmol) in 200 ml of dichloromethane was added pyridinium 
tosylate (2.00 g, 7.97 mmol) at room temperature. The reaction mixture 
was stirred for 10 hrs and was then concentrated. Chromatography on 
silica gel using 8:1 hexane/ether as solvent afforded 22.8 g (90%) of 
159 as a colorless liquid. NMR (CDCl^ ) 6 1.05 - 1.32 (m, 6 H), 2.88 (t, 
2 H, J = 7 Hz), 3.30 - 3.87 (m, 4 H), 4.68 (q, 1 H, J = 6 Hz), 6.04 
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(d, 1 H, J = 4 Hz), 6.18 - 6.25 (m, 1 H), 7.22 - 7.32 (m, 1 H). C-13 
NMR 15.28, 19.77, 29.07, 60.80, 63.01, 99.56, 105.93, 110.23, 141.05, 
153.21 ppm. IR (film) 2990, 2920, 1605, 1510, 1450, 1385, 1345, 1140, 
1090, 1060, 730 cm"^ . 
2-[2-(Benzyloxy)ethyl]furan 160 
To a suspension of sodium hydride (4.30 g, 179 mmol) in 80 ml of 
THF at 0°C was added 156 (11.91 g, 106 mmol) in 40 ml of THF. After 
stirring for 30 minutes, benzyl bromide (12.8 ml, 108 mmol) was added 
dropwise. The reaction mixture was stirred for 12 hrs and was then 
poured into ice water. The aqueous phase was extracted with ether. 
The extracts were combined, washed with water and brine, dried, and 
concentrated in vacuo. Distillation afforded 19.70 g (92%) of 160 
(bp 100°C, 4 mm Hg). NMR (CDCl^ ) 6 2.94 (t, 2 H, J = 7 Hz), 3.73 (t, 
2 H, J = 7 Hz), 4.53 (s, 2 H), 6.06 (d, 1 H, J = 4 Hz), 6.22 - 6.34 
(m, 1 H), 7.29 (s, 6 H). C-13 NMR 28.87, 68.28, 72.83, 105.87, 110.16, 
127.52, 128.30, 138.32, 140.99, 153.02 ppm. IR (film) 3010, 2940, 
1590, 1495, 1443, 1355, 1135, 1090, 995, 720 cm"^ . 
5-[2-(Benzyloxy)ethyl]-2-furancarboxaldehyde 1^  
To a solution of N,N-dimethylformamide (3.87 ml, 50 mmol) in 10 ml 
of 1,2-dichloroethane at 0°C was added phosphorus oxychloride (4.60 ml, 
49.5 mmol). After stirring for 20 minutes, furan ^ 0 (10.0 g, 49.5 
mmol) in 10 ml 1,2-dichloroethane was added. The reaction mixture was 
stirred for 1 hr at 0°C and then 4 hrs at room temperature. The reaction 
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mixture was then poured into ice water and was neutralized with sodium 
carbonate. The aqueous phase was extracted with ether. The extracts 
were combined, washed with water and brine, dried, and concentrated 
in vacuo. Chromatography on silica gel using 2:1 hexane/ether as 
solvent yielded 9.80 g (86%) of 1^  as a colorless liquid. NMR (CDCl^ ) 
6 2.98 (t, 2 H, J = 7 Hz), 3.73 (t, 2 H, J = 7 Hz), 4.48 (s, 2 H), 
6.27 (d, 1 H, J = 4 Hz), 7.12 (d, 1 H, J = 4 Hz), 7.25 (s, 5 H), 9.50 
(s, 1 H). C-13 NMR 29.20, 67.18, 72.96, 109.71, 114.84, 122.97, 
127.52, 128.30, 137.93, 151.98, 160.56, 176.82 ppm. IR (film) 2880, 
1680, 1520, 1400, 1365, 1285, 1200, 1100, 1025, 800, 750, 700 cm"^ . 
High resolution mass spectrum for ®^ciuires 230.09430; measured 
230.09423. 
2-[(2,5-Dimethoxyphenyl)methyl]-5-(2-hydroxyethyl)furan and 
2-[(2,5-dimethoxypheny1)hydroxymethyl]-5-(2-hydroxyethyl)furan 1^ 4 
Using the tandem alkylation-reduction procedure developed for 128, 
a mixture of ^ 2 (minor) and 164 (major) was obtained from p-dimethoxy-
benzene (2.76 g, 20 mmol), aldehyde ^ 1 (4.68 g, 20 mmol), and lithium 
wire (46 mmol). Recrystallization from ethyl acetate/hexane yielded 
3.22 g (58%) of 1^  (mp 99 - 100°C). MHz 300, NMR (CDCl^ ) 6 1.65 - 2.04 
(br s, 2 H), 2.87 (t, 2 H, J = 6.5 Hz), 3.76 (s, 3 H), 3.79 (s, 3 H), 
3.86 (t, 2 H, J = 6.5 Hz), 5.95 (d, 2 H, J = 3 Hz), 6.01 (d, 1 H, 
3= 3 Hz), 6.82 - 6.87 (m, 2 H), 6.94 (d, 1 H, J = 3 Hz). C-13 NMR 
31.67, 55.73, 56.19, 60.80, 65.74, 107.04, 107.88, 112.05, 113.61, 
113.80, 130.39, 150.87, 152.82, 153.80, 154.45 ppm. IR (CDCl^ ) 3600 -
3100 (br), 2930, 1495, 1455, 1270, 1220, 1180, 1045, 910 cm"^ . 
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Resubmitting the mixture of 162 and ^ 4 to the reduction conditions 
(2 equivalents of lithium, 15 minutes) afforded 1^ . Chromatography 
on silica gel using 2:1 hexane/ethyl acetate provided a 63% yield of 
162 as a colorless oil. MHz 300, NMR (CDCl^ ) $ 1.88 (br s, 1 H), 
2.83 (t, 2 H, J = 6.5 Hz), 3.72 (s, 3 H), 3.77 (s, 3 H), 3.82 (t, 2 H, 
J = 6.5 Hz), 3.90 (s, 2 H), 5.88 (d, 1 H, J = 3 Hz), 5.98 (d, 1 H, 
J = 3 Hz), 6.69 - 6.80 (m, 3 H). C-13 NMR 28.48, 31.67, 55.54, 56.12, 
61.00, 106.78, 106.97, 111.72, 116.40, 128.04, 151.59, 153.02, 153.60 
ppm. IR (film) 3640 - 3180 (br), 2950, 2840, 1500, 1220, 1045, 900, 
720 cm~^ . High resolution mass spectrum for requires 262.12051; 
found 262.12040. 
7-Carboxy-8-[(2,5-dimethoxypheny1)methyl]-4,11-dioxatricyclo[6.2.1.0^ '^ ]-
undecan-5-one 167 
Cycloaddition of 1^  (1.23 g, 4.69 mmol) with maleic anhydride 
(0.46 g, 4.70 mmol) was accomplished using the procedure developed 
for 129. After stirring for 3 days, the reaction mixture was filtered 
and washed with cold ether to yield 1.29 g (75%) of crude 1^ . 
Using the procedure developed for 130, the crude adduct 1^  
(1.29 g, 3.58 mmol) in 75 ml of THF was hydrogenated to afford 167. 
Recrystallization from acetone yielded 1.03 g (80%) of ^ 7 (mp 256 -
2570c). The overall yield of 1^  from ^ 2 was 60%. Due to the in­
solubility of acid 167, it was esterified with diazomethane and was 
characterized as the methyl ester (mp 170 - 171°C). MHz 300, NMR (CDCl^ ) 
5 1.50 - 1.71 (m, 4 H), 2.08 - 2.22 (m, 2 H), 2.90 (d, 1 H, J = 14.3 Hz), 
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2.95 (d, 1 H, J = SA Hz), 3.25 (d, 1 H, J = 14.3 Hz), 3.47 (d, 1 H, 
J = 9.4 Hz), 3.73 (s, 3 H), 3.76 and 3.77 (2 s, 6 H), 4.39 - 4.44 (m, 
1 H), 4.79 - 4.82 (m, 1 H), 6.75 - 6.80 (m, 2 H), 6.92 (d, 1 H, J = 
3 Hz). C-13 NMR 20.10, 30.48, 32.24, 36.17, 51.34, 51.87, 55.65, 
55.88, 58.82, 66.00, 82.05, 88.26, 111.27, 112.46, 117.78, 125.95, 
151.78, 153.20, 171.36, 171.50 ppm. IR (CDCl,) 2980, 2860, 1735, 
1720 (sh), 1505, 1470, 1435, 1365, 1270, 1230, 1050 cm"^ . Elemental 
analysis calculated for 2^.98; H, 6.12. Found: C, 
62.95; H, 6.11. 
8,11-Dimethoxy-l,12-dioxo-2-oxa-l,2,3,4,4a,5,6,6a,7,12,12a,12b-dodeca-
hydro-4a,6a-epoxybenz[a]anthracene ^ 8 
To a suspension of Ig (0.526 g, 1.45 mmol) in 14 ml of dichloro-
methane at 0°C was added trifluoroacetic anhydride (0.43 ml, 3.04 mmol). 
The mixture was stirred for 30 minutes. Tin tetrachloride (0.51 ml, 
4.36 mmol) was added at 0°C. The reaction mixture was stirred for 2 
hrs at 0°C and then for 5 hrs .at room temperature. The reaction 
mixture was poured into ice water and was extracted with dichloro-
methane. The extracts were combined, washed with brine, dried, and 
concentrated vacuo. The residue was dissolved in chloroform and 
was filtered through silica gel to afford 0.424 g (85%) of 1^ 8 (mp 
230 - 2330c). MHz 300, NMR (CDCl^ ) 6 1.60 - 1.73 (m, 2 H), 1.97 -
2.20 (m, 4 H), 2.88 (d, 1 H, J = 7.8 Hz), 3.21 (d, 1 H, J = 20 Hz), 
3.38 (d, 1 H, J = 20 Hz), 3.62 (d, 1 H, J = 7.8 Hz), 3.79 (s, 3 H), 
3.82 (s, 3 H), 4.30 - 4.38 (m, 2 H), 6.78 (d, 1 H, J = 9 Hz), 6.95 
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(d, 1 H, J = 9 Hz. C-i3 NMR 28.26, 28.73, 35.65, 36.50, 48.01, 55.88, 
56.32, 61.16, 65.25, 84.23, 85.23, 110.18, 114.64, 122.60, 129.11, 
149.94, 152.59, 172.40, 194.85 pptn. IR (CDCl^ ) 2950, 1700, 1590, 
1475, 1385, 1260, 1235, 1080, 970 cm~^ . Elemental analysis calculated 
for C, 66.27; H, 5.85. Found: C, 64.96; H, 5.94. 
8,ll-Dimethoxy-12-hydroxv-2-oxa-l-oxo-l,2,3,4,5,6-hexahydrobenz[a]-
anthracene ^ 9 
To a solution of 1^  (0.226 g, 0.66 mmol) in 5 ml of dichloro-
methane at 0°C was added boron trifluoride etherate (0.09 ml, 0.73 
mmol). The reaction mixture was stirred for 20 hrs at room temperature 
and was then poured into ice water. The aqueous phase was extracted 
with dichloromethane. The extracts were combined, washed with water, 
dried, and concentrated in vacuo. Chromatography on silica gel using 
2:1 chloroform/hexane as solvent afforded 0.144 g (67%) of 1^  (mp 
155 - 158°C). MHz 300, NMR (COCl^ ) ô 2.36 (t, 2 H, J = 7 Hz), 2.57 
(t, 2 H, J = 7 Hz), 2.81 (t, 2 H, J = 7 Hz), 3.87 (s, 3 H), 3.92 (s, 
3 H), 4.37 (t, 2 H, J = 7 Hz), 6.56 (s, 2 H), 7.47 (s, 1 H), 9.94 (s, 
1 H). C-13 NMR 28.75, 29.05, 30.17, 55.63, 56.15, 64.96, 103.15, 
103.60, 110.44, 113.97, 115.06, 124.15, 127.22, 136.77, 149.58, 149.77, 
150.36, 154.13, 162.21 ppm. IR (CDCl^ ) 3350, 3060, 2945, 1720, 1610, 
1500, 1360, 1145, 1100, 1070 cm"^ . MS (m/e) 326, 311, 296, 282, 267, 
253. Elemental analysis calculated for C^ H^^ gO^ : C, 69.93; H, 5.56. 
Found: C, 70.05; H, 5.60. 
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General procedure for oxidative-demethylation of para-dimethoxy aryl ethers 
To a mixture of the dimethoxyaryl r;ther (1 mmol) and silver (II) 
oxide (4 mmol) in 10 ml of THF was addecJ 6N HNO^  (1.0 ml). The reaction 
mixture was stirred for 5 minutes and was then poured into water. The 
aqueous phase was extracted with chloroform. The extracts were combined, 
washed with water, dried, and concentrated in vacuo. 
a. Quinones 170 and HI NMR (CDCl^  6 2.46 - 2.88 (m), 3.95 
(s), 4.49 (t, J = 6 Hz), 7.27 (d, J = 3 Hz), 12.26 (s), 12.50 (s). IR 
(CDCl^ ) 3400 - 3000 (br), 2940, 1720, 1600, 1445, 1390, 1255, 1205, 
1145 cm'l. MS (m/e) 340 and 310. 
b. Quinone 172  MHz 300, NMR (CDCl^ ) g 1.86 - 2.20 (m), 3.02 
(d, J = 19 Hz), 3.04 (d, J = 7 Hz), 3.26 (d, J = 19 Hz), 3.57 (d, 
J = 7 Hz), 4.20 - 4.38 (m), 6.73 (d, J = 10 Hz), 6.85 (d, J = 10 Hz). 
IR (CDCl^ ) 1710, 1655, 1460, 1380, 1280, 1260, 1050 cm"^ . 
c. Quinone n8 MHz 300, NMR (CDCl^ ) ô 1.78 - 2.22 (m), 
3.06 (d, J = 8 Hz), 3.19 (d, ^  = 21 Hz), 3.39 (d, J = 21 Hz), 3.70 
(d, J = 8 Hz), 4.24 - 4.35 (m), 7.69 - 7.77 (m), 8.02 - 8.11 (m). 
2-[2-(Benzyloxy)ethyl]-5-[(1,4-dimethoxy-2-naphthaleny1)methyl]furan 17^  
To a solution of 2-bromo-l,4-dimethoxynaphthalene (97) (3.60 g, 
13.5 mmol) in 15 ml of ether at -78°C was added n-butyllithium (14.0 
mmol). After stirring for 10 minutes, aldehyde 1^  (3.10 g, 13.5 mmol) 
in 20 ml of ether was added. The reaction mixture was allowed to warm 
to room temperature and was stirred for 30 minutes. The reaction 
mixture was then poured into water and was extracted with ether. The 
extracts were combined, washed with water and brine, dried, and 
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concentrated iji vacuo. The crude alcohol was dissolved in 20 ml of THF 
and was added to a solution of sodium borohydride (1.02 g, 27 mmol) in 
20 ml of distilled diglyme at 0°C. Boron trifluoride etherate (8.3 ml, 
67 mmol) was added dropwise to the reaction mixture. The reaction 
mixture was stirred for 10 hrs and was then carefully quenched with 
water at 0°C. The aqueous phase was extracted with ether. The extracts 
were combined, washed with water and brine, dried, and concentrated 
in vacuo. Chromatography on silica gel using 8:1 hexane/ether afforded 
2.98 g (55%) of 174 as a colorless oil. MHz 300, NMR (CDCl^ ) 5 2.92 (t, 
2 H, J = 6.2 Hz), 3.71 (t, 2 H, J = 6.2 Hz), 3.88 (s, 3 H), 3.91 
(s, 3 H), 4.12 (S, 2 H), 4.50 (s, 2 H), 5.91 (d, 1 H, J = 3 Hz), 5.99 
(d, 1 H, J = 3 Hz), 6.64 (s, 1 H), 7.30 (s, 5 H), 7.42 - 7.57 (m, 2 H), 
8.04 (d, 1 H, J = 8 Hz), 8.21 (d, 1 H, J = 8 Hz). C-13 NMR 28.66, 
29.05, 55.64, 62.35, 68.45, 72.95, 105.72, 106.67, 106.96, 121.90, 
122.32, 125.08, 125.84, 125.98, 126.44, 126.53, 127.59, 128.37, 128.62, 
138.31, 147.07, 151.83, 152.96 ppm. IR (film) 3050, 2940, 2860, 1600, 
1460, 1365, 1260, 1220, 1085, 1000, 750 cm"^ . High resolution mass 
spectrum for ^ 26^ 26^  ^requires 402.18312; measured 402.18256. 
2-[(1,4-Dimethoxy-2-naphthaleny1)methyl]-5-[2-(hydroxy)ethyl]furan 157 
To a suspension of activated 10% Pd/C (0.22 g) in 10 ml of ethanol 
under a hydrogen atmosphere was added 174 (2.25 g, 5.60 mmol) in 20 ml 
of ethanol. The reaction mixture was stirred for 8 hrs, filtered through 
celite, and concentrated in vacuo. Chromatography on silica gel using 
1:1 hexane/ether yielded 1.62 g (93%) of ^ 7 as a colorless oil. MHz 
300, NMR (CDCl,) 6 1.65 (br s, 1 H), 2.85 (t, 2 H, J = 6.2 Hz), 3.83 
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(t, 2 H, J = 6.2 Hz), 3.89 (s, 3 H), 3.93 (s, 3 H), 4.13 (s, 2 H), 
5.91 (d, 1 H, J = 3 Hz), 6.00 (d, 1 H, J = 3 Hz), 6.63 (s, 1 H), 
7.45 - 7.53 (m, 2 H), 8.04 (d, 1 H, J = 8 Hz), 8.20 (d, 1 H, J = 
8 Hz). C-13 NMR 28.76, 31.77, 55.68, 61.21, 62.35, 105.63, 106.96, 
107.28, 121.89, 122.27, 122.34, 125.14, 125.80, 126.60, 128.64, 147.11, 
151.59, 151.87, 153.51 ppm. IR (film) 3700 - 3200 (br), 2960, 1600, 
1560, 1375, 1265, 1220, 1090, 1000 cm~^ . High resolution mass spectrum 
for C^ gHggO^  requires 312.13616; measured 312.13541. 
7-Carboxy-8-[(l,4-dimethoxv-2-naphthalenyl)methyl]-4,ll-dioxatricyclo-
[6.2.1.0^ '^ ]undec-9-en-5-one 175 
Cycloaddition of 157 (1.50 g, 4.80 mmol) with maleic anhydride 
(0.47 g, 4.80 mmol) was accomplished using the procedure developed for 
9^. After stirring for 4 days, the yellow gel was dissolved in ether. 
With rapid stirring, hexane was added dropwise. The solid was filtered 
and washed with cold ether to yield 1.20 g (60%) of crude 175. MHz 300, 
NMR (CDClj) 6 2.32 - 2.44 (m, 2 H), 2.87 (d, 1 H, J = 8.7 Hz), 3.28 
(d, 1 H, J = 8.7 Hz), 3.30 (d, 1 H, J = 14.4 Hz), 3.65 (d, 1 H, J = 
14.4 Hz), 4.43 - 4.51 (m, 1 H), 4.73 - 4.82 (m, 1 H), 6.21 (d, 1 H, 
3 = 5.7 Hz), 2.26 (d, 1 H, J = 5.7 Hz), 6.79 (s, 1 H), 7.42 - 7.54 
(m, 2 H), 8.02 (d, 1 H, J = 8.4 Hz), 8.19 (d, 1 H, j = 8.4 Hz). 
The filtrate was concentrated in vacuo. The residue (0.71 g) 
was dissolved in 20 ml of methanol. After the addition of lithium 
hydroxide (0.30 g), the solution was refluxed for 12 hrs. The solution 
was then concentrated and diluted with water. The aqueous phase was 
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extracted with ether. The extracts were combined, washed with water 
and brine, dried, and concentrated in vacuo. Chromatography on silica 
gel using 1:1 hexane/ether afforded 0.37 g of 157. 
7-Carboxy-8-[(l,A-dimethoxy-2-naphthalenyl)methyl]-A,ll-dioxatricyclo-
C6.2.1.0^ '^ ]undecan-9-one 158 
Using the procedure developed for 130, the crude adduct 175 
(1.20 g, 2.93 mmol) in 30 ml of acetone was hydrogenated to afford 
1.14 g (95%) of r75 (mp 138 - 145°C) as a mixture of diastereomers. 
MHz 300, NMR (CDCl ) 6 1.47 - 1.61 (m, 4 H), 2.14 - 2.22 (m, 2 H), 
3.02 (d, 1 H, J = 9.2 Hz), 3.30 (d, 1 H, J = 14 Hz), 3.45 (d, 1 H, 
J = 14 Hz), 3.55 (d, 1 H, J = 9.2 Hz), 3.85 (s, 3 H), 3.95 (s, 3 H), 
4.41 - 4.45 (m, 1 H), 4.80 - 4.84 (m, 1 H), 6.90 is, 1 H), 7.45 - 7.54 
(m, 2 H), 8.01 (d, 1 H, J = 7.9 Hz), 8.20 (d, 1 H, J = 7.9 Hz). C-13 
NMR 28.06, 31.00, 32.42, 36.14, 51.19, 55.68, 58.90, 61.99, 65.82, 
66.15, 82.29, 88.50, 106.70, 121.87, 122.20, 124.75, 125.05, 125.81, 
126.37, 128.20, 147.51, 151.36, 172.40, 174.52 ppm. IR (CDCl,) 
3400 - 2820 (br), 1730, 1600, 1465, 1372, 1265, 1230, 1160, 1090 cm"^ . 
Elemental analysis calculated for ^^ -98; H, 5.87. Found: 
C, 64.70; H, 6.50. 
8,13-Dimethoxy-l,14-dioxo-2-oxa-l,2,3,4,4a,5,6,6a,7,14,14a,14b-dodeca-
hydro-4a,ôa-epoxybenz[a]naphthacene HI 
Using the procedure developed for 1^ , acid ^ 8 (0.627 g, 1.52 
mmol) was converted to ketolactone 177. Recrystallization from 
acetone/hexane afforded 0.45 g (75%) of 177 (mp 208 - 210°C). MHz 300, 
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NMR (CDClj) 6 2.05 - 2.19 (m, 4 H), 3.02 (d, 1 H, J = 8 Hz), 3.46 
(d, 1 H, J = 18.9 Hz), 3.65 (d, 1 H, J = 18.9 Hz), 3.66 (d, 1 H, J = 
8 Hz), 3.92 (s, 3 H), 3.98 (s, 3 H), 4.32 - 4.36 (m, 2 H), 7.52 (t, 
1 H, J = 7 Hz), 7.61 (t, 1 H, J = Hz), 8.04 (d, 1 H, J = 8.2 Hz), 
8.27 (d, 1 H, J = 8.2 Hz). C-13 NMR 28.20, 28.75, 35.98, 36.54, 49.34, 
61.20, 61.37, 63.95, 65.42, 84.26, 85.49, 121.78, 122.01, 124.61, 
125.68, 126.20, 128.53, 128.60, 130.89, 148.42, 153.82, 171.50, 195.44 
ppm. IR (CDCI3) 2960, 1715, 1615, 1450, 1375, 1340, 1270, 1080, 1035 
cm~^ . Elemental analysis calculated for 70.04; H, 5.62. 
Found C, 69.90; H, 5.69. 
4a,14-Dihydroxy-2-oxa-l,8,13-trioxo-l,2,3,4,4a,5,6,8,13,14b-decahydro-
benz[a]naphthacene 179 
Using the general oxidative-demethylation procedure, ketolactone 
177 (0.083 g, 0.21 mmol) was oxidized to quinone 178. The crude quinone 
was dissolved in 5 ml of acetone. After the addition of concentrated 
HCl (1 drop), the reaction mixture was stirred for 20 hrs. The yellow 
precipitate was filtered and washed with cold acetone to afford 0.023 g 
(30%) of 179 (mp 263 - 268°C) as a mixture of diastereomers. MHz 300, 
NMR (dL-DMSO) S 1.99 - 2.48 (m, 4 H), 4.19 and 5.12 (two s, 1 H), 4.43 -
6 
4.64 (m, 2 H), 7.53 (s, 1 H), 7.92 - 7.98 (m, 2 H), 8.18 - 8.26 (m, 
2 H), 13.01 (s, 1 H). MS (m/e) 364, 346, 316, 302, 292, 275, 263. High 
resolution mass spectrum for ^ 21^ 1606 364.0947; found 364.0960. 
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